Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:piroxicam
go back to main search page
Accession:CHEBI:8249 term browser browse the term
Definition:A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling.
Synonyms:exact_synonym: 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
 related_synonym: 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;   FELDENE;   Formula=C15H13N3O4S;   InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20);   InChIKey=QYSPLQLAKJAUJT-UHFFFAOYSA-N;   Pyroxycam;   SMILES=CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O;   piroxicamum
 xref: Beilstein:627692;   CAS:36322-90-4;   DrugBank:DB00554;   Drug_Central:2210;   HMDB:HMDB0014694;   KEGG:C01608;   KEGG:D00127
 xref_mesh: MESH:D010894
 xref: PMID:11142413;   PMID:12154043;   PMID:28166217;   Patent:DE1943265;   Patent:US3591584;   Reaxys:627692;   Wikipedia:Piroxicam


show annotations for term's descendants           Sort by:
 
piroxicam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aars1 alanyl-tRNA synthetase 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA] CTD PMID:21858171 NCBI chr19:43,193,264...43,215,281
Ensembl chr19:43,193,257...43,215,281
JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression ISO Piroxicam results in decreased expression of ABCD3 mRNA CTD PMID:21858171 NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA CTD PMID:21858171 NCBI chr10:56,619,321...56,624,468
Ensembl chr10:56,619,303...56,624,526
JBrowse link
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Piroxicam results in decreased expression of ACKR3 mRNA CTD PMID:19192274 NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
JBrowse link
G Adipor2 adiponectin receptor 2 decreases expression ISO Piroxicam results in decreased expression of ADIPOR2 mRNA CTD PMID:21858171 NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
JBrowse link
G Adm adrenomedullin increases expression ISO Piroxicam results in increased expression of ADM mRNA CTD PMID:21858171 NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
JBrowse link
G Adora2a adenosine A2a receptor decreases expression ISO Piroxicam results in decreased expression of ADORA2A mRNA CTD PMID:19192274 NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
JBrowse link
G Agfg1 ArfGAP with FG repeats 1 decreases expression ISO Piroxicam results in decreased expression of AGFG1 mRNA CTD PMID:21858171 NCBI chr 9:88,607,508...88,663,486
Ensembl chr 9:88,607,508...88,662,224
JBrowse link
G Aimp1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 decreases expression ISO Piroxicam results in decreased expression of AIMP1 mRNA CTD PMID:21858171 NCBI chr 2:237,727,782...237,751,327
Ensembl chr 2:237,727,764...237,751,378
JBrowse link
G Ak2 adenylate kinase 2 increases expression ISO Piroxicam results in increased expression of AK2 mRNA CTD PMID:21858171 NCBI chr 5:147,185,474...147,204,050
Ensembl chr 5:147,185,474...147,204,050
JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AKAP12 mRNA] CTD PMID:21858171 NCBI chr 1:40,816,130...40,906,582
Ensembl chr 1:40,816,107...40,906,581
JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 decreases expression ISO Piroxicam results in decreased expression of AKR7A2 mRNA CTD PMID:21858171 NCBI chr 5:157,759,448...157,768,473
Ensembl chr 5:157,759,416...157,768,471
JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO Piroxicam results in decreased expression of ALDH1A3 mRNA CTD PMID:21858171 NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882
JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO Piroxicam results in decreased expression of AMIGO2 mRNA CTD PMID:19192274 NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221
JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of ANP32A mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA]
CTD PMID:21858171 NCBI chr 8:67,295,578...67,333,075
Ensembl chr 8:67,295,727...67,333,247
JBrowse link
G Anxa10 annexin A10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ANXA10 mRNA CTD PMID:21858171 NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465
JBrowse link
G Aplp2 amyloid beta precursor like protein 2 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of APLP2 mRNA] CTD PMID:21858171 NCBI chr 8:32,298,526...32,328,821
Ensembl chr 8:32,298,532...32,328,839
JBrowse link
G Arc activity-regulated cytoskeleton-associated protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ARC mRNA CTD PMID:21858171 NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA] CTD PMID:21858171 NCBI chr 2:187,964,100...188,022,847
Ensembl chr 2:187,977,008...188,021,377
JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 increases expression ISO Piroxicam results in increased expression of ARL6IP5 mRNA CTD PMID:21858171 NCBI chr 4:129,574,363...129,598,240
Ensembl chr 4:129,574,264...129,598,915
JBrowse link
G Asf1a anti-silencing function 1A histone chaperone decreases expression ISO Piroxicam results in decreased expression of ASF1A mRNA CTD PMID:21858171 NCBI chr20:34,894,419...34,909,265
Ensembl chr20:34,894,419...34,909,265
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO Piroxicam results in increased expression of ASNS mRNA CTD PMID:21858171 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of ASPM mRNA] CTD PMID:21858171 NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 decreases expression ISO Piroxicam results in decreased expression of ATAD2 mRNA CTD PMID:21858171 NCBI chr 7:97,984,754...98,027,379
Ensembl chr 7:97,984,862...98,026,052
JBrowse link
G Atf3 activating transcription factor 3 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of ATF3 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATF3 mRNA]
CTD PMID:21858171 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Atf4 activating transcription factor 4 decreases expression ISO Piroxicam results in decreased expression of ATF4 mRNA CTD PMID:21858171 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATP1B1 mRNA] CTD PMID:21858171 NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004
JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression ISO Piroxicam results in decreased expression of ATP2A2 mRNA CTD PMID:21858171 NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ATP5MC1 mRNA CTD PMID:21858171 NCBI chr10:83,895,941...83,898,640
Ensembl chr10:83,895,947...83,898,527
JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D decreases expression ISO Piroxicam results in decreased expression of ATP6V1D mRNA CTD PMID:21858171 NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
JBrowse link
G Aurka aurora kinase A decreases expression ISO Piroxicam results in decreased expression of AURKA mRNA CTD PMID:21858171 NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
JBrowse link
G Avpi1 arginine vasopressin-induced 1 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of AVPI1 mRNA] CTD PMID:21858171 NCBI chr 1:261,365,590...261,371,519
Ensembl chr 1:261,365,590...261,371,508
JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO Piroxicam results in decreased expression of BAG5 mRNA CTD PMID:21858171 NCBI chr 6:136,180,640...136,185,651
Ensembl chr 6:136,182,006...136,185,651
JBrowse link
G Bag6 BAG cochaperone 6 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BAG6 mRNA CTD PMID:21858171 NCBI chr20:5,124,512...5,138,084
Ensembl chr20:5,125,349...5,138,084
JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO Piroxicam results in decreased expression of BARD1 mRNA CTD PMID:21858171 NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A decreases expression ISO Piroxicam results in decreased expression of BAZ1A mRNA CTD PMID:21858171 NCBI chr 6:75,793,223...75,873,854
Ensembl chr 6:75,793,960...75,874,235
JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of BCCIP mRNA] CTD PMID:21858171 NCBI chr 1:205,777,474...205,789,887
Ensembl chr 1:205,777,130...205,790,175
JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression ISO Piroxicam results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 NCBI chr 8:96,551,424...96,559,527
Ensembl chr 8:96,551,245...96,559,483
JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BCLAF1 mRNA CTD PMID:21858171 NCBI chr 1:15,799,753...15,828,838
Ensembl chr 1:15,782,477...15,860,624
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] CTD PMID:21858171 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Bmp2k BMP-2 inducible kinase increases expression ISO Piroxicam results in increased expression of BMP2K mRNA CTD PMID:21858171 NCBI chr14:14,126,086...14,226,823
Ensembl chr14:14,129,725...14,192,048
JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex, subunit 3 decreases expression ISO Piroxicam results in decreased expression of BRCC3 mRNA CTD PMID:21858171 NCBI chr 9:9,863,380...9,865,920
Ensembl chr 9:9,863,404...9,865,920
JBrowse link
G Brms1 BRMS1, transcriptional repressor and anoikis regulator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BRMS1 mRNA CTD PMID:21858171 NCBI chr 1:220,325,352...220,334,616 JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO Piroxicam results in decreased expression of BST2 mRNA CTD PMID:19192274 NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of BTG1 mRNA] CTD PMID:21858171 NCBI chr 7:37,812,831...37,815,088
Ensembl chr 7:37,812,831...37,815,088
JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BUB1 mRNA CTD PMID:21858171 NCBI chr 3:120,373,604...120,404,910
Ensembl chr 3:120,373,604...120,404,910
JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of BUB1B mRNA] CTD PMID:21858171 NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
JBrowse link
G C1d C1D nuclear receptor corepressor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of C1D mRNA CTD PMID:21858171 NCBI chr14:100,415,645...100,427,878
Ensembl chr14:100,415,668...100,427,260
JBrowse link
G Cacybp calcyclin binding protein multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CACYBP mRNA] CTD PMID:21858171 NCBI chr13:77,948,771...77,959,089
Ensembl chr13:77,948,771...77,959,110
JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CAD mRNA CTD PMID:21858171 NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
JBrowse link
G Cadm1 cell adhesion molecule 1 decreases expression ISO Piroxicam results in decreased expression of CADM1 mRNA CTD PMID:21858171 NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
JBrowse link
G Calm1 calmodulin 1 decreases expression ISO Piroxicam results in decreased expression of CALM1 mRNA CTD PMID:21858171 NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 increases expression ISO Piroxicam results in increased expression of CAND1 mRNA CTD PMID:21858171 NCBI chr 7:62,124,362...62,162,451
Ensembl chr 7:62,124,362...62,162,453
JBrowse link
G Canx calnexin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CANX mRNA CTD PMID:21858171 NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
JBrowse link
G Capg capping actin protein, gelsolin like decreases expression ISO Piroxicam results in decreased expression of CAPG mRNA CTD PMID:21858171 NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
JBrowse link
G Capn7 calpain 7 decreases expression ISO Piroxicam results in decreased expression of CAPN7 mRNA CTD PMID:21858171 NCBI chr16:7,435,541...7,472,483
Ensembl chr16:7,435,634...7,471,807
JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CAPZA2 mRNA] CTD PMID:21858171 NCBI chr 4:44,936,290...44,972,270
Ensembl chr 4:44,936,290...44,972,267
JBrowse link
G Cast calpastatin increases expression ISO Piroxicam results in increased expression of CAST mRNA CTD PMID:21858171 NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
JBrowse link
G Cav1 caveolin 1 decreases expression ISO Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
JBrowse link
G Ccdc85b coiled-coil domain containing 85B increases expression ISO Piroxicam results in increased expression of CCDC85B mRNA CTD PMID:21858171 NCBI chr 1:220,835,647...220,837,220 JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Piroxicam results in decreased expression of CCL20 mRNA; Piroxicam results in decreased expression of CCL20 protein CTD PMID:19192274 NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Piroxicam results in increased expression of CCN1 mRNA CTD PMID:19192274 NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression ISO Piroxicam results in decreased expression of CCN2 mRNA CTD PMID:21858171 NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO Piroxicam results in increased expression of CCN5 mRNA CTD PMID:19192274 NCBI chr 3:160,207,969...160,219,316
Ensembl chr 3:160,207,913...160,219,331
JBrowse link
G Ccna2 cyclin A2 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CCNA2 mRNA] CTD PMID:21858171 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CCNB1 mRNA CTD PMID:21858171 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnb2 cyclin B2 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CCNB2 mRNA] CTD PMID:21858171 NCBI chr 8:76,847,972...76,861,165 JBrowse link
G Ccnc cyclin C decreases expression ISO Piroxicam results in decreased expression of CCNC mRNA CTD PMID:21858171 NCBI chr 5:35,865,598...35,883,732
Ensembl chr 5:35,865,605...35,883,706
JBrowse link
G Ccnd1 cyclin D1 increases expression ISO Piroxicam results in increased expression of CCND1 mRNA CTD PMID:21858171 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Piroxicam results in decreased expression of CCND3 mRNA CTD PMID:21858171 NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
JBrowse link
G Cd44 CD44 molecule (Indian blood group) increases expression ISO Piroxicam results in increased expression of CD44 mRNA CTD PMID:21858171 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
JBrowse link
G Cd55 CD55 molecule (Cromer blood group) increases expression ISO Piroxicam results in increased expression of CD55 mRNA CTD PMID:21858171 NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
JBrowse link
G Cdc25a cell division cycle 25A decreases expression ISO Piroxicam results in decreased expression of CDC25A mRNA CTD PMID:21858171 NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CDC42 mRNA CTD PMID:21858171 NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
JBrowse link
G Cdc45 cell division cycle 45 decreases expression ISO Piroxicam results in decreased expression of CDC45 mRNA CTD PMID:21858171 NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
JBrowse link
G Cdc6 cell division cycle 6 increases expression ISO Piroxicam results in increased expression of CDC6 mRNA CTD PMID:21858171 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CDCA3 mRNA] CTD PMID:21858171 NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
JBrowse link
G Cdca4 cell division cycle associated 4 increases expression ISO Piroxicam results in increased expression of CDCA4 mRNA CTD PMID:21858171 NCBI chr 6:137,396,133...137,421,283
Ensembl chr 6:137,396,140...137,421,283
JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CDCA8 mRNA] CTD PMID:21858171 NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK1 mRNA] CTD PMID:21858171 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK2 mRNA] CTD PMID:21858171 NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
affects localization
ISO [Cisplatin co-treated with Piroxicam] affects the localization of CDKN1A protein; [Cisplatin co-treated with Piroxicam] results in decreased expression of CDKN1A protein; [Piroxicam co-treated with Cisplatin] results in increased expression of CDKN1A mRNA; CDKN1A results in increased susceptibility to [Cisplatin co-treated with Piroxicam]
Piroxicam affects the localization of CDKN1A protein
CTD PMID:21858171 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A protein] CTD PMID:12189186 NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CDKN3 mRNA CTD PMID:21858171 NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA]
Piroxicam results in decreased expression of CEBPB mRNA
CTD PMID:21858171 NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma multiple interactions
increases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CEBPG mRNA]
Piroxicam results in increased expression of CEBPG mRNA
CTD PMID:21858171 NCBI chr 1:91,286,956...91,297,459
Ensembl chr 1:91,287,917...91,296,656
JBrowse link
G Cenpa centromere protein A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CENPA mRNA CTD PMID:21858171 NCBI chr 6:27,072,259...27,080,863
Ensembl chr 6:27,072,166...27,080,856
JBrowse link
G Cenpe centromere protein E decreases expression ISO Piroxicam results in decreased expression of CENPE mRNA CTD PMID:21858171 NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
JBrowse link
G Cep170 centrosomal protein 170 increases expression ISO Piroxicam results in increased expression of CEP170 mRNA CTD PMID:21858171 NCBI chr13:94,807,090...94,887,448
Ensembl chr13:94,807,756...94,859,436
JBrowse link
G Cep55 centrosomal protein 55 decreases expression ISO Piroxicam results in decreased expression of CEP55 mRNA CTD PMID:21858171 NCBI chr 1:256,745,251...256,760,794
Ensembl chr 1:256,745,288...256,760,796
JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CES2 mRNA CTD PMID:21858171 NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
JBrowse link
G Ciz1 CDKN1A interacting zinc finger protein 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA] CTD PMID:21858171 NCBI chr 3:11,392,046...11,409,218
Ensembl chr 3:11,392,791...11,410,180
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] CTD PMID:21858171 NCBI chr17:13,587,664...13,593,423
Ensembl chr17:13,587,665...13,593,423
JBrowse link
G Clcn3 chloride voltage-gated channel 3 decreases expression ISO Piroxicam results in decreased expression of CLCN3 mRNA CTD PMID:21858171 NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148
JBrowse link
G Clgn calmegin decreases expression ISO Piroxicam results in decreased expression of CLGN mRNA CTD PMID:19192274 NCBI chr19:24,545,257...24,578,527
Ensembl chr19:24,545,318...24,576,798
JBrowse link
G Cnn3 calponin 3 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CNN3 mRNA] CTD PMID:21858171 NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Piroxicam results in increased expression of COL1A1 mRNA CTD PMID:19192274 NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
JBrowse link
G Colec12 collectin sub-family member 12 increases expression ISO Piroxicam results in increased expression of COLEC12 mRNA CTD PMID:19192274 NCBI chr18:867,048...1,054,047
Ensembl chr18:867,048...1,052,606
JBrowse link
G Cops3 COP9 signalosome subunit 3 decreases expression ISO Piroxicam results in decreased expression of COPS3 mRNA CTD PMID:21858171 NCBI chr10:46,182,680...46,206,083
Ensembl chr10:46,182,687...46,206,135
JBrowse link
G Coq8a coenzyme Q8A multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of COQ8A mRNA] CTD PMID:21858171 NCBI chr13:98,451,629...98,480,438
Ensembl chr13:98,451,637...98,480,419
JBrowse link
G Cpsf1 cleavage and polyadenylation specific factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CPSF1 mRNA CTD PMID:21858171 NCBI chr 7:117,661,779...117,672,373
Ensembl chr 7:117,661,661...117,672,373
JBrowse link
G Cpsf6 cleavage and polyadenylation specific factor 6 decreases expression ISO Piroxicam results in decreased expression of CPSF6 mRNA CTD PMID:21858171 NCBI chr 7:60,385,688...60,417,661
Ensembl chr 7:60,385,688...60,416,925
JBrowse link
G Crk CRK proto-oncogene, adaptor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CRK mRNA CTD PMID:21858171 NCBI chr10:63,829,731...63,855,999
Ensembl chr10:63,829,807...63,852,780
JBrowse link
G Crtc3 CREB regulated transcription coactivator 3 increases expression ISO Piroxicam results in increased expression of CRTC3 mRNA CTD PMID:21858171 NCBI chr 1:142,398,248...142,500,562
Ensembl chr 1:142,393,207...142,500,383
JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CSNK1A1 mRNA] CTD PMID:21858171 NCBI chr18:56,887,722...56,910,610
Ensembl chr18:56,887,354...56,918,345
JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CSNK2A2 mRNA CTD PMID:21858171 NCBI chr19:9,972,537...10,012,043
Ensembl chr19:9,972,537...10,012,043
JBrowse link
G Ctnnal1 catenin alpha-like 1 decreases expression ISO Piroxicam results in decreased expression of CTNNAL1 mRNA CTD PMID:21858171 NCBI chr 5:73,561,249...73,621,070
Ensembl chr 5:73,561,450...73,621,070
JBrowse link
G Ctsc cathepsin C decreases expression ISO Piroxicam results in decreased expression of CTSC mRNA CTD PMID:21858171 NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
JBrowse link
G Cul4b cullin 4B decreases expression ISO Piroxicam results in decreased expression of CUL4B mRNA CTD PMID:21858171 NCBI chr  X:124,831,391...124,870,329
Ensembl chr  X:124,832,628...124,870,329
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression
decreases expression
ISO Piroxicam results in increased expression of CXCL2 mRNA
Piroxicam results in decreased expression of CXCL2 mRNA
CTD PMID:19192274, PMID:21858171 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Piroxicam results in decreased expression of CXCR4 mRNA CTD PMID:19192274 NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
JBrowse link
G Cyb5b cytochrome b5 type B decreases expression ISO Piroxicam results in decreased expression of CYB5B mRNA CTD PMID:21858171 NCBI chr19:39,357,814...39,391,680
Ensembl chr19:39,357,791...39,393,189
JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA CTD PMID:21858171 NCBI chr10:31,278,746...31,419,235
Ensembl chr10:31,278,746...31,419,235
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
decreases expression
decreases activity
ISO Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA]
Piroxicam results in decreased expression of CYP19A1 mRNA
Piroxicam results in decreased activity of CYP19A1 protein
CTD PMID:15964185, PMID:19147701 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Dbf4 DBF4 zinc finger increases expression
multiple interactions
ISO Piroxicam results in increased expression of DBF4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DBF4 mRNA]
CTD PMID:21858171 NCBI chr 4:22,898,527...22,914,091
Ensembl chr 4:22,898,527...22,914,177
JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase decreases expression ISO Piroxicam results in decreased expression of DCXR mRNA CTD PMID:21858171 NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
JBrowse link
G Ddb2 damage specific DNA binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DDB2 mRNA CTD PMID:21858171 NCBI chr 3:80,030,437...80,052,984
Ensembl chr 3:80,030,437...80,052,953
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DDIT3 mRNA] CTD PMID:21858171 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddx19a DEAD-box helicase 19A decreases expression ISO Piroxicam results in decreased expression of DDX19A mRNA CTD PMID:21858171 NCBI chr19:43,251,510...43,271,865
Ensembl chr19:43,217,161...43,275,287
JBrowse link
G Ddx39a DExD-box helicase 39A decreases expression ISO Piroxicam results in decreased expression of DDX39A mRNA CTD PMID:21858171 NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953
JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked decreases expression ISO Piroxicam results in decreased expression of DDX3X mRNA CTD PMID:21858171 NCBI chr  X:10,400,363...10,414,010
Ensembl chr  X:10,400,366...10,413,995
JBrowse link
G Ddx58 DEXD/H-box helicase 58 decreases expression ISO Piroxicam results in decreased expression of DDX58 mRNA CTD PMID:19192274 NCBI chr 5:56,486,584...56,536,898
Ensembl chr 5:56,500,734...56,536,772
JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 increases expression ISO Piroxicam results in increased expression of DEGS1 mRNA CTD PMID:21858171 NCBI chr13:100,665,265...100,672,731
Ensembl chr13:100,666,075...100,672,731
JBrowse link
G Dffa DNA fragmentation factor subunit alpha decreases expression ISO Piroxicam results in decreased expression of DFFA mRNA CTD PMID:21858171 NCBI chr 5:165,922,893...165,935,822
Ensembl chr 5:165,922,915...165,935,821
JBrowse link
G Dhfr dihydrofolate reductase decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of DHFR mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DHFR mRNA]
CTD PMID:21858171 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression ISO Piroxicam results in decreased expression of DHX9 mRNA CTD PMID:21858171 NCBI chr13:70,885,503...70,922,278
Ensembl chr13:70,885,504...70,922,245
JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression ISO Piroxicam results in decreased expression of DIAPH1 mRNA CTD PMID:21858171 NCBI chr18:30,972,907...31,071,371
Ensembl chr18:30,972,907...31,071,371
JBrowse link
G Dlgap5 DLG associated protein 5 increases expression
multiple interactions
ISO Piroxicam results in increased expression of DLGAP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DLGAP5 mRNA]
CTD PMID:21858171 NCBI chr15:24,167,484...24,199,417
Ensembl chr15:24,167,486...24,199,341
JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of DNAJA1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of DNAJA1 mRNA]
CTD PMID:21858171 NCBI chr 5:57,028,467...57,039,378
Ensembl chr 5:57,028,467...57,039,378
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression ISO Piroxicam results in decreased expression of DNAJB1 mRNA CTD PMID:21858171 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
JBrowse link
G Dnajb12 DnaJ heat shock protein family (Hsp40) member B12 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DNAJB12 mRNA CTD PMID:21858171 NCBI chr20:29,445,510...29,463,739
Ensembl chr20:29,445,510...29,463,738
JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases expression ISO Piroxicam results in decreased expression of DNAJB6 mRNA CTD PMID:21858171 NCBI chr 4:2,711,329...2,774,969
Ensembl chr 4:2,711,385...2,774,890
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA] CTD PMID:21858171 NCBI chr15:4,356,512...4,360,788
Ensembl chr15:4,356,261...4,360,564
JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Piroxicam results in increased expression of DNMT1 mRNA CTD PMID:21858171 NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
JBrowse link
G Donson DNA replication fork stabilization factor DONSON multiple interactions
increases expression
ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of DONSON mRNA] CTD PMID:21858171 NCBI chr11:31,834,608...31,847,751
Ensembl chr11:31,837,839...31,847,490
JBrowse link
G Dpm1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DPM1 mRNA CTD PMID:21858171 NCBI chr 3:164,966,637...164,986,180
Ensembl chr 3:164,966,637...164,986,180
JBrowse link
G Dpp3 dipeptidylpeptidase 3 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DPP3 mRNA] CTD PMID:21858171 NCBI chr 1:220,166,124...220,189,762
Ensembl chr 1:220,166,127...220,188,541
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DPYD mRNA CTD PMID:21858171 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 decreases expression ISO Piroxicam results in decreased expression of DPYSL2 mRNA CTD PMID:21858171 NCBI chr15:43,475,640...43,581,725
Ensembl chr15:43,477,629...43,542,939
JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog decreases expression ISO Piroxicam results in decreased expression of DTL mRNA CTD PMID:21858171 NCBI chr13:110,219,276...110,257,345
Ensembl chr13:110,220,283...110,257,367
JBrowse link
G Dtymk deoxythymidylate kinase multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of DTYMK mRNA] CTD PMID:21858171 NCBI chr 9:100,921,565...100,930,399
Ensembl chr 9:100,921,565...100,930,399
JBrowse link
G Dusp1 dual specificity phosphatase 1 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of DUSP1 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DUSP1 mRNA]
CTD PMID:21858171 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DUT mRNA] CTD PMID:21858171 NCBI chr 3:117,514,399...117,525,450
Ensembl chr 3:117,514,444...117,525,446
JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DYNC1H1 mRNA CTD PMID:21858171 NCBI chr 6:134,958,854...135,085,769
Ensembl chr 6:134,958,854...135,085,769
JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 decreases expression ISO Piroxicam results in decreased expression of EBNA1BP2 mRNA CTD PMID:21858171 NCBI chr 5:137,458,692...137,463,255
Ensembl chr 5:137,670,123...137,674,802
JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO Piroxicam results in decreased expression of EBP mRNA CTD PMID:21858171 NCBI chr  X:15,049,394...15,055,782
Ensembl chr  X:15,049,462...15,055,781
JBrowse link
G Ect2 epithelial cell transforming 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of ECT2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ECT2 mRNA]
CTD PMID:21858171 NCBI chr 2:112,769,385...112,831,476
Ensembl chr 2:112,769,385...112,831,476
JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 decreases expression ISO Piroxicam results in decreased expression of EEF1E1 mRNA CTD PMID:21858171 NCBI chr17:26,785,017...26,795,723
Ensembl chr17:26,785,029...26,797,161
JBrowse link
G Egfr epidermal growth factor receptor decreases expression
multiple interactions
ISO
EXP
Piroxicam results in decreased expression of EGFR mRNA
Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein]
CTD PMID:15309881, PMID:21858171 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 decreases expression ISO Piroxicam results in decreased expression of EID1 mRNA CTD PMID:21858171 NCBI chr 3:117,938,500...117,940,219
Ensembl chr 3:117,938,500...117,940,219
JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF1AX mRNA] CTD PMID:21858171 NCBI chr  X:37,579,959...37,595,300
Ensembl chr  X:37,579,957...37,595,486
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha decreases expression ISO Piroxicam results in decreased expression of EIF2S1 mRNA CTD PMID:21858171 NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J decreases expression ISO Piroxicam results in decreased expression of EIF3J mRNA CTD PMID:21858171 NCBI chr 3:113,976,687...113,998,925
Ensembl chr 3:113,976,687...113,998,922
JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 decreases expression ISO Piroxicam results in decreased expression of EIF4A2 mRNA CTD PMID:21858171 NCBI chr11:81,373,047...81,379,680
Ensembl chr11:81,373,048...81,379,871
JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EIF4B mRNA CTD PMID:21858171 NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF4E mRNA] CTD PMID:21858171 NCBI chr 2:243,819,616...243,853,987
Ensembl chr 2:243,820,661...243,852,631
JBrowse link
G Eif4e2 eukaryotic translation initiation factor 4E family member 2 decreases expression ISO Piroxicam results in decreased expression of EIF4E2 mRNA CTD PMID:21858171 NCBI chr 9:94,310,476...94,325,445
Ensembl chr 9:94,307,852...94,336,831
JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO Piroxicam results in decreased expression of EIF5 mRNA CTD PMID:21858171 NCBI chr 6:136,002,983...136,011,409
Ensembl chr 6:136,004,214...136,011,406
JBrowse link
G Eif5b eukaryotic translation initiation factor 5B multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF5B mRNA] CTD PMID:21858171 NCBI chr 9:44,658,724...44,713,518
Ensembl chr 9:44,681,494...44,713,199
JBrowse link
G Epas1 endothelial PAS domain protein 1 decreases expression ISO Piroxicam results in decreased expression of EPAS1 mRNA CTD PMID:21858171 NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of EPB41L2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of EPB41L2 mRNA]
CTD PMID:21858171 NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ESM1 mRNA] CTD PMID:21858171 NCBI chr 2:45,104,392...45,113,130
Ensembl chr 2:45,104,305...45,113,131
JBrowse link
G Ewsr1 EWS RNA-binding protein 1 decreases expression ISO Piroxicam results in decreased expression of EWSR1 mRNA CTD PMID:21858171 NCBI chr14:85,322,105...85,350,826
Ensembl chr14:85,322,296...85,350,948
JBrowse link
G Exoc3 exocyst complex component 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of EXOC3 mRNA CTD PMID:21858171 NCBI chr 1:31,700,953...31,731,726
Ensembl chr 1:31,700,953...31,731,815
JBrowse link
G Exosc8 exosome component 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EXOSC8 mRNA CTD PMID:21858171 NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940
JBrowse link
G Exosc9 exosome component 9 decreases expression ISO Piroxicam results in decreased expression of EXOSC9 mRNA CTD PMID:21858171 NCBI chr 2:123,264,679...123,275,623
Ensembl chr 2:123,264,694...123,294,880
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression ISO Piroxicam results in decreased expression of EZH2 mRNA CTD PMID:21858171 NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
JBrowse link
G F8a1 coagulation factor VIII-associated 1 decreases expression ISO Piroxicam results in decreased expression of F8A1 mRNA CTD PMID:21858171 NCBI chr 1:147,021,436...147,022,950
Ensembl chr 1:147,021,436...147,022,950
JBrowse link
G Fam111a FAM111 trypsin like peptidase A increases expression ISO Piroxicam results in increased expression of FAM111A mRNA CTD PMID:21858171 NCBI chr 1:229,003,778...229,019,532
Ensembl chr 1:229,003,961...229,019,527
JBrowse link
G Fanci FA complementation group I increases expression ISO Piroxicam results in increased expression of FANCI mRNA CTD PMID:21858171 NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
JBrowse link
G Fancl FA complementation group L increases expression ISO Piroxicam results in increased expression of FANCL mRNA CTD PMID:21858171 NCBI chr14:110,675,306...110,740,880
Ensembl chr14:110,676,090...110,740,317
JBrowse link
G Fbxo9 f-box protein 9 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] CTD PMID:21858171 NCBI chr 8:85,388,331...85,413,896
Ensembl chr 8:85,388,333...85,413,484
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of FDFT1 mRNA] CTD PMID:21858171 NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO Piroxicam results in decreased expression of FDPS mRNA CTD PMID:21858171 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fdxr ferredoxin reductase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FDXR mRNA CTD PMID:21858171 NCBI chr10:103,817,724...103,826,413
Ensembl chr10:103,817,704...103,826,448
JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of FEN1 mRNA] CTD PMID:21858171 NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of FGF2 mRNA] CTD PMID:21858171 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
JBrowse link
G Flii FLII, actin remodeling protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FLII mRNA CTD PMID:21858171 NCBI chr10:46,955,460...46,969,468
Ensembl chr10:46,955,487...46,969,406
JBrowse link
G Flnb filamin B decreases expression ISO Piroxicam results in decreased expression of FLNB mRNA CTD PMID:21858171 NCBI chr15:18,750,152...18,883,019
Ensembl chr15:18,750,118...18,883,005
JBrowse link
G Foxm1 forkhead box M1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FOXM1 mRNA CTD PMID:21858171 NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
JBrowse link
G Fst follistatin decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of FST mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of FST mRNA]
CTD PMID:21858171 NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
JBrowse link
G Fut8 fucosyltransferase 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of FUT8 mRNA CTD PMID:21858171 NCBI chr 6:100,305,957...100,537,208
Ensembl chr 6:100,337,226...100,537,224
JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of FYN mRNA CTD PMID:21858171 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
JBrowse link
G Gar1 GAR1 ribonucleoprotein decreases expression ISO Piroxicam results in decreased expression of GAR1 mRNA CTD PMID:21858171 NCBI chr 2:235,250,453...235,258,464
Ensembl chr 2:235,250,453...235,257,731
JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Piroxicam results in decreased expression of GBP1 mRNA CTD PMID:19192274 NCBI chr 2:248,343,334...248,423,402
Ensembl chr 2:248,398,917...248,409,570
JBrowse link
G Gcsh glycine cleavage system protein H decreases expression ISO Piroxicam results in decreased expression of GCSH mRNA CTD PMID:21858171 NCBI chr19:49,522,054...49,532,811
Ensembl chr19:49,522,054...49,532,811
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GDF15 mRNA] CTD PMID:21858171 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
JBrowse link
G Gins1 GINS complex subunit 1 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of GINS1 mRNA] CTD PMID:21858171 NCBI chr 3:146,695,366...146,716,787
Ensembl chr 3:146,695,344...146,716,816
JBrowse link
G Gins2 GINS complex subunit 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of GINS2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of GINS2 mRNA]
CTD PMID:21858171 NCBI chr19:54,151,048...54,163,701
Ensembl chr19:54,151,048...54,163,608
JBrowse link
G Gins3 GINS complex subunit 3 increases expression ISO Piroxicam results in increased expression of GINS3 mRNA CTD PMID:21858171 NCBI chr19:9,835,113...9,843,649
Ensembl chr19:9,835,057...9,843,673
JBrowse link
G Gla galactosidase, alpha decreases expression ISO Piroxicam results in decreased expression of GLA mRNA CTD PMID:21858171 NCBI chr  X:105,405,915...105,417,331
Ensembl chr  X:105,406,792...105,417,323
JBrowse link
G Glipr1 GLI pathogenesis-related 1 decreases expression ISO Piroxicam results in decreased expression of GLIPR1 mRNA CTD PMID:21858171 NCBI chr 7:54,767,828...54,778,823
Ensembl chr 7:54,767,827...54,778,848
JBrowse link
G Gm2a GM2 ganglioside activator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GM2A mRNA CTD PMID:21858171 NCBI chr10:40,438,394...40,450,927
Ensembl chr10:40,438,356...40,450,930
JBrowse link
G Gmnn geminin, DNA replication inhibitor decreases expression ISO Piroxicam results in decreased expression of GMNN mRNA CTD PMID:21858171 NCBI chr17:42,302,523...42,310,783
Ensembl chr17:42,302,540...42,310,783
JBrowse link
G Gng11 G protein subunit gamma 11 decreases expression ISO Piroxicam results in decreased expression of GNG11 mRNA CTD PMID:21858171 NCBI chr 4:28,989,170...28,994,610
Ensembl chr 4:28,989,115...28,993,621
JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPAA1 mRNA CTD PMID:21858171 NCBI chr 7:117,394,367...117,397,950
Ensembl chr 7:117,394,372...117,397,956
JBrowse link
G Gpc1 glypican 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPC1 mRNA CTD PMID:21858171 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818
JBrowse link
G Grn granulin precursor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GRN mRNA] CTD PMID:21858171 NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
JBrowse link
G Gsdme gasdermin E decreases expression ISO Piroxicam results in decreased expression of GSDME mRNA CTD PMID:19192274 NCBI chr 4:79,934,075...79,999,678
Ensembl chr 4:79,934,887...79,989,572
JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression EXP Piroxicam results in increased expression of GSTT1 protein CTD PMID:9729437 NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 decreases expression ISO Piroxicam results in decreased expression of GTF2IRD1 mRNA CTD PMID:21858171 NCBI chr12:25,264,052...25,370,947
Ensembl chr12:25,264,192...25,371,001
JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GULP1 mRNA CTD PMID:21858171 NCBI chr 9:51,263,484...51,538,066
Ensembl chr 9:51,263,622...51,538,072
JBrowse link
G H2ax H2A.X variant histone decreases expression ISO Piroxicam results in decreased expression of H2AX mRNA CTD PMID:21858171 NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
JBrowse link
G Hat1 histone acetyltransferase 1 decreases expression ISO Piroxicam results in decreased expression of HAT1 mRNA CTD PMID:21858171 NCBI chr 3:58,022,395...58,070,067
Ensembl chr 3:58,022,238...58,070,068
JBrowse link
G Hexim1 HEXIM P-TEFb complex subunit 1 decreases expression ISO Piroxicam results in decreased expression of HEXIM1 mRNA CTD PMID:21858171 NCBI chr10:91,200,874...91,202,986
Ensembl chr10:91,200,874...91,202,984
JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO Piroxicam results in decreased expression of HILPDA mRNA CTD PMID:19192274 NCBI chr 4:56,547,600...56,550,584
Ensembl chr 4:56,549,739...56,549,993
JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMGA2 mRNA CTD PMID:21858171 NCBI chr 7:65,159,944...65,275,408
Ensembl chr 7:65,159,944...65,275,408
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression ISO Piroxicam results in decreased expression of HMGCR mRNA CTD PMID:21858171 NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
JBrowse link
G Hmgn3 high mobility group nucleosomal binding domain 3 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HMGN3 mRNA] CTD PMID:21858171 NCBI chr 8:90,628,203...90,665,055
Ensembl chr 8:90,628,209...90,664,554
JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMMR mRNA CTD PMID:21858171 NCBI chr10:25,861,490...25,890,639
Ensembl chr10:25,861,490...25,890,639
JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of HNRNPA3 mRNA] CTD PMID:21858171 NCBI chr 3:62,481,222...62,491,356
Ensembl chr 3:62,481,323...62,487,227
JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HNRNPD mRNA] CTD PMID:21858171 NCBI chr14:11,256,163...11,274,684
Ensembl chr14:11,256,268...11,274,578
JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HNRNPL mRNA CTD PMID:21858171 NCBI chr 1:86,994,090...87,006,776
Ensembl chr 1:86,996,093...87,006,776
JBrowse link
G Hoxa9 homeobox A9 decreases expression ISO Piroxicam results in decreased expression of HOXA9 mRNA CTD PMID:21858171
G Hs2st1 heparan sulfate 2-O-sulfotransferase 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA] CTD PMID:21858171 NCBI chr 2:250,467,428...250,600,517
Ensembl chr 2:250,467,429...250,600,517
JBrowse link
G Hsbp1 heat shock factor binding protein 1 decreases expression ISO Piroxicam results in decreased expression of HSBP1 mRNA CTD PMID:21858171 NCBI chr19:51,985,196...51,989,528
Ensembl chr19:51,985,170...51,989,544
JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases expression ISO Piroxicam results in decreased expression of HSD11B1 mRNA CTD PMID:19192274 NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
JBrowse link
G Hsd17b11 hydroxysteroid (17-beta) dehydrogenase 11 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSD17B11 mRNA CTD PMID:21858171 NCBI chr14:7,054,724...7,104,567
Ensembl chr14:7,073,445...7,104,566
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of HSPA1A mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of HSPA1A mRNA]
CTD PMID:21858171 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HSPA1B mRNA] CTD PMID:21858171 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSPA4L mRNA CTD PMID:21858171 NCBI chr 2:127,625,737...127,682,864
Ensembl chr 2:127,625,683...127,677,503
JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 decreases expression ISO Piroxicam results in decreased expression of HSPA9 mRNA CTD PMID:21858171 NCBI chr18:27,731,072...27,749,235
Ensembl chr18:27,731,072...27,749,235
JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPE1 mRNA] CTD PMID:21858171 NCBI chr 9:61,691,246...61,724,948
Ensembl chr 9:61,692,154...61,694,599
JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 decreases expression ISO Piroxicam results in decreased expression of HSPH1 mRNA CTD PMID:21858171 NCBI chr12:6,322,685...6,341,898
Ensembl chr12:6,322,668...6,341,902
JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha decreases expression ISO Piroxicam results in decreased expression of IDH3A mRNA CTD PMID:21858171 NCBI chr 8:59,164,601...59,183,899
Ensembl chr 8:59,164,572...59,183,908
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Piroxicam results in decreased expression of IDI1 mRNA CTD PMID:21858171 NCBI chr17:57,976,266...57,984,036
Ensembl chr17:57,976,268...57,984,036
JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 decreases expression ISO Piroxicam results in decreased expression of IFI27 mRNA CTD PMID:19192274 NCBI chr 6:127,327,959...127,334,430
Ensembl chr 6:127,327,959...127,334,428
JBrowse link
G Ifi44l interferon-induced protein 44-like decreases expression ISO Piroxicam results in decreased expression of IFI44L mRNA CTD PMID:19192274 NCBI chr 2:256,948,722...256,979,573
Ensembl chr 2:256,964,860...256,978,668
JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Piroxicam results in decreased expression of IL1RN mRNA CTD PMID:19192274 NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Piroxicam results in decreased expression of IL23A mRNA CTD PMID:19192274 NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
JBrowse link
G Il6 interleukin 6 decreases expression ISO Piroxicam results in decreased expression of IL6 mRNA; Piroxicam results in decreased expression of IL6 protein CTD PMID:19192274 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Ilf3 interleukin enhancer binding factor 3 decreases expression ISO Piroxicam results in decreased expression of ILF3 mRNA CTD PMID:21858171 NCBI chr 8:22,402,877...22,440,984
Ensembl chr 8:22,402,890...22,440,885
JBrowse link
G Insig1 insulin induced gene 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] CTD PMID:21858171 NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
JBrowse link
G Ipo7 importin 7 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of IPO7 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of IPO7 mRNA]
CTD PMID:21858171 NCBI chr 1:174,655,939...174,696,173
Ensembl chr 1:174,655,939...174,696,173
JBrowse link
G Iqcb1 IQ motif containing B1 decreases expression ISO Piroxicam results in decreased expression of IQCB1 mRNA CTD PMID:21858171 NCBI chr11:66,824,059...66,878,585
Ensembl chr11:66,824,065...66,878,551
JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression ISO Piroxicam results in decreased expression of IRS2 mRNA CTD PMID:21858171 NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Piroxicam results in decreased expression of ISG15 mRNA CTD PMID:19192274 NCBI chr 5:173,624,862...173,629,124
Ensembl chr 5:173,624,310...173,626,248
JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 decreases expression ISO Piroxicam results in decreased expression of ISG20 mRNA CTD PMID:19192274 NCBI chr 1:140,602,553...140,608,892
Ensembl chr 1:140,601,791...140,608,946
JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein decreases expression ISO Piroxicam results in decreased expression of ITGB3BP mRNA CTD PMID:21858171 NCBI chr 5:118,476,410...118,541,928
Ensembl chr 5:118,476,430...118,673,780
JBrowse link
G Jag2 jagged canonical Notch ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of JAG2 mRNA CTD PMID:21858171 NCBI chr 6:137,711,144...137,733,331
Ensembl chr 6:137,711,155...137,733,026
JBrowse link
G Jmjd6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression ISO Piroxicam results in increased expression of JMJD6 mRNA CTD PMID:21858171 NCBI chr10:105,781,752...105,787,803
Ensembl chr10:105,781,753...105,787,803
JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Piroxicam results in decreased expression of JUND mRNA CTD PMID:21858171 NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KCNMA1 mRNA CTD PMID:21858171 NCBI chr15:344,204...1,048,849
Ensembl chr15:344,360...1,047,956
JBrowse link
G Kdelr2 KDEL endoplasmic reticulum protein retention receptor 2 decreases expression ISO Piroxicam results in decreased expression of KDELR2 mRNA CTD PMID:21858171 NCBI chr12:13,192,452...13,210,758
Ensembl chr12:13,192,453...13,210,758
JBrowse link
G Kif11 kinesin family member 11 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of KIF11 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KIF11 mRNA]
CTD PMID:21858171 NCBI chr 1:256,035,866...256,088,299
Ensembl chr 1:256,035,866...256,088,299
JBrowse link
G Kif14 kinesin family member 14 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of KIF14 mRNA] CTD PMID:21858171 NCBI chr13:53,350,073...53,421,992
Ensembl chr13:53,351,717...53,420,111
JBrowse link
G Kif18a kinesin family member 18A decreases expression ISO Piroxicam results in decreased expression of KIF18A mRNA CTD PMID:21858171 NCBI chr 3:100,366,168...100,426,867
Ensembl chr 3:100,366,168...100,427,030
JBrowse link
G Kif20a kinesin family member 20A multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of KIF20A mRNA] CTD PMID:21858171 NCBI chr18:27,424,328...27,432,814
Ensembl chr18:27,424,328...27,432,814
JBrowse link
G Kif23 kinesin family member 23 decreases expression ISO Piroxicam results in decreased expression of KIF23 mRNA CTD PMID:21858171 NCBI chr 8:66,866,043...66,893,241
Ensembl chr 8:66,866,082...66,893,196
JBrowse link
G Kif2c kinesin family member 2C increases expression ISO Piroxicam results in increased expression of KIF2C mRNA CTD PMID:21858171 NCBI chr 5:136,027,923...136,053,268
Ensembl chr 5:136,027,934...136,053,210
JBrowse link
G Kif4a kinesin family member 4A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KIF4A mRNA CTD PMID:21858171 NCBI chr  X:70,461,700...70,561,084
Ensembl chr  X:70,461,718...70,561,189
JBrowse link
G Klf4 Kruppel like factor 4 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KLF4 mRNA CTD PMID:21858171 NCBI chr 5:72,283,311...72,287,669
Ensembl chr 5:72,283,313...72,287,669
JBrowse link
G Klhl21 kelch-like family member 21 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA CTD PMID:21858171 NCBI chr 5:169,181,418...169,190,073
Ensembl chr 5:169,181,418...169,190,073
JBrowse link
G Kpna1 karyopherin subunit alpha 1 decreases expression ISO Piroxicam results in decreased expression of KPNA1 mRNA CTD PMID:21858171 NCBI chr11:67,652,573...67,717,180
Ensembl chr11:67,652,577...67,703,025
JBrowse link
G Kpna2 karyopherin subunit alpha 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of KPNA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNA2 mRNA]
CTD PMID:21858171 NCBI chr10:95,200,029...95,212,111
Ensembl chr10:95,200,030...95,212,111
JBrowse link
G Kpnb1 karyopherin subunit beta 1 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNB1 mRNA] CTD PMID:21858171 NCBI chr10:85,096,517...85,124,641
Ensembl chr10:85,093,841...85,124,644
JBrowse link
G Krr1 KRR1, small subunit processome component homolog increases expression ISO Piroxicam results in increased expression of KRR1 mRNA CTD PMID:21858171 NCBI chr 7:54,756,043...54,767,477
Ensembl chr 7:54,756,043...54,767,471
JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Piroxicam results in decreased expression of LAMB3 mRNA CTD PMID:19192274 NCBI chr13:112,031,614...112,073,187
Ensembl chr13:112,031,594...112,073,186
JBrowse link
G Lamc1 laminin subunit gamma 1 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of LAMC1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LAMC1 mRNA]
CTD PMID:21858171 NCBI chr13:70,656,727...70,783,515
Ensembl chr13:70,658,707...70,783,515
JBrowse link
G Lbr lamin B receptor multiple interactions
increases expression
ISO Cisplatin affects the reaction [Piroxicam results in increased expression of LBR mRNA] CTD PMID:21858171 NCBI chr13:100,431,390...100,450,209 JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LDLR mRNA] CTD PMID:21858171 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of LGALS3BP mRNA CTD PMID:21858171 NCBI chr10:107,415,334...107,424,672
Ensembl chr10:107,415,326...107,424,710
JBrowse link
G Lhfpl2 LHFPL tetraspan subfamily member 2 increases expression ISO Piroxicam results in increased expression of LHFPL2 mRNA CTD PMID:21858171 NCBI chr 2:23,705,491...23,852,021
Ensembl chr 2:23,770,721...23,852,021
JBrowse link
G LOC100364500 RT1 class I, locus CE11-like multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-A mRNA CTD PMID:21858171 NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
JBrowse link
G Lrba LPS responsive beige-like anchor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of LRBA mRNA CTD PMID:21858171 NCBI chr 2:185,590,983...186,110,491
Ensembl chr 2:185,524,774...186,110,495
JBrowse link
G Lxn latexin increases expression ISO Piroxicam results in increased expression of LXN mRNA CTD PMID:19192274 NCBI chr 2:164,628,565...164,634,434
Ensembl chr 2:164,628,566...164,634,434
JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression ISO Piroxicam results in decreased expression of LY6E mRNA CTD PMID:19192274 NCBI chr 7:116,355,426...116,359,862
Ensembl chr 7:116,355,698...116,359,862
JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 increases expression ISO Piroxicam results in increased expression of MAD2L1 mRNA CTD PMID:21858171 NCBI chr 4:97,530,993...97,543,179
Ensembl chr 4:97,531,083...97,537,086
JBrowse link
G Magoh mago homolog, exon junction complex subunit increases expression ISO Piroxicam results in increased expression of MAGOH mRNA CTD PMID:21858171 NCBI chr 5:127,480,465...127,487,617
Ensembl chr 5:127,480,485...127,487,603
JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MANF mRNA] CTD PMID:21858171 NCBI chr 8:115,623,175...115,626,408
Ensembl chr 8:115,623,178...115,626,380
JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO Piroxicam results in decreased expression of MARCKS mRNA CTD PMID:19192274 NCBI chr20:42,966,140...42,971,838
Ensembl chr20:42,966,140...42,971,838
JBrowse link
G Mars1 methionyl-tRNA synthetase 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA] CTD PMID:21858171 NCBI chr 7:70,585,011...70,602,425
Ensembl chr 7:70,585,013...70,602,310
JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO Piroxicam results in decreased expression of MCAM mRNA CTD PMID:21858171 NCBI chr 8:48,472,824...48,481,005
Ensembl chr 8:48,472,824...48,481,001
JBrowse link
G Mcm3 minichromosome maintenance complex component 3 decreases expression ISO Piroxicam results in decreased expression of MCM3 mRNA CTD PMID:21858171 NCBI chr 9:26,914,057...26,932,201
Ensembl chr 9:26,914,057...26,932,201
JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of MCM4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MCM4 mRNA]
CTD PMID:21858171 NCBI chr11:89,511,191...89,524,892
Ensembl chr11:89,511,191...89,524,892
JBrowse link
G Mcm5 minichromosome maintenance complex component 5 increases expression ISO Piroxicam results in increased expression of MCM5 mRNA CTD PMID:21858171 NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278
JBrowse link
G Mcm6 minichromosome maintenance complex component 6 decreases expression ISO Piroxicam results in decreased expression of MCM6 mRNA CTD PMID:21858171 NCBI chr13:45,042,882...45,068,073
Ensembl chr13:45,042,882...45,068,077
JBrowse link
G Mdk midkine increases expression ISO Piroxicam results in increased expression of MDK mRNA CTD PMID:21858171 NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
JBrowse link
G Med21 mediator complex subunit 21 decreases expression ISO Piroxicam results in decreased expression of MED21 mRNA CTD PMID:21858171 NCBI chr 4:180,961,194...180,968,155
Ensembl chr 4:180,961,142...180,968,123
JBrowse link
G Med27 mediator complex subunit 27 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of MED27 mRNA CTD PMID:21858171 NCBI chr 3:7,884,793...8,059,003
Ensembl chr 3:7,884,822...8,059,003
JBrowse link
G Meis2 Meis homeobox 2 decreases expression ISO Piroxicam results in decreased expression of MEIS2 mRNA CTD PMID:21858171 NCBI chr 3:107,560,172...107,762,732
Ensembl chr 3:107,559,997...107,760,589
JBrowse link
G Mest mesoderm specific transcript decreases expression ISO Piroxicam results in decreased expression of MEST mRNA CTD PMID:21858171 NCBI chr 4:58,052,786...58,063,227
Ensembl chr 4:58,053,041...58,063,138
JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of MET mRNA CTD PMID:19192274 NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of MGAT2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MGAT2 mRNA]
CTD PMID:21858171 NCBI chr 6:91,476,698...91,479,187
Ensembl chr 6:91,476,698...91,479,183
JBrowse link
G Mink1 misshapen-like kinase 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of MINK1 mRNA] CTD PMID:21858171 NCBI chr10:57,185,310...57,238,531
Ensembl chr10:57,185,347...57,238,531
JBrowse link
G Mis18a MIS18 kinetochore protein A multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of MIS18A mRNA] CTD PMID:21858171 NCBI chr11:30,880,231...30,893,262
Ensembl chr11:30,879,887...30,893,310
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Piroxicam results in decreased expression of MKI67 mRNA CTD PMID:21858171 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
JBrowse link
G Mllt11 MLLT11, transcription factor 7 cofactor decreases expression ISO Piroxicam results in decreased expression of MLLT11 mRNA CTD PMID:21858171 NCBI chr 2:196,392,936...196,402,106
Ensembl chr 2:196,392,938...196,402,106
JBrowse link
G Mmp10 matrix metallopeptidase 10 decreases expression ISO Piroxicam results in decreased expression of MMP10 mRNA CTD PMID:19192274 NCBI chr 8:5,734,348...5,742,243
Ensembl chr 8:5,734,348...5,742,243
JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases activity ISO Piroxicam results in decreased activity of MMP2 protein CTD PMID:15990687 NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
JBrowse link
G Mob1a MOB kinase activator 1A decreases expression ISO Piroxicam results in decreased expression of MOB1A mRNA CTD PMID:21858171 NCBI chr 4:115,024,927...115,041,904
Ensembl chr 4:115,024,927...115,041,899
JBrowse link
G Mpo myeloperoxidase decreases activity
increases expression
multiple interactions
increases activity
EXP Piroxicam results in decreased activity of MPO
Piroxicam results in increased expression of MPO protein
pantoprazole inhibits the reaction [Piroxicam results in increased expression of MPO protein]
Piroxicam results in increased activity of MPO protein
CTD PMID:11996850, PMID:15309881, PMID:16080005 NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
JBrowse link
G Mr1 major histocompatibility complex, class I-related affects expression ISO Piroxicam affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr13:72,771,992...72,789,861
Ensembl chr13:72,771,984...72,789,841
JBrowse link
G Mrpl13 mitochondrial ribosomal protein L13 decreases expression ISO Piroxicam results in decreased expression of MRPL13 mRNA CTD PMID:21858171 NCBI chr 7:95,288,400...95,309,997
Ensembl chr 7:95,288,376...95,310,005
JBrowse link
G Mrpl16 mitochondrial ribosomal protein L16 decreases expression ISO Piroxicam results in decreased expression of MRPL16 mRNA CTD PMID:21858171 NCBI chr 1:228,142,778...228,147,590
Ensembl chr 1:228,142,778...228,147,579
JBrowse link
G Msh2 mutS homolog 2 decreases expression ISO Piroxicam results in decreased expression of MSH2 mRNA CTD PMID:21858171 NCBI chr 6:11,215,951...11,274,916
Ensembl chr 6:11,215,963...11,274,932
JBrowse link
G Msh6 mutS homolog 6 decreases expression ISO Piroxicam results in decreased expression of MSH6 mRNA CTD PMID:21858171 NCBI chr 6:11,644,565...11,662,389
Ensembl chr 6:11,644,578...11,662,499
JBrowse link
G Msmo1 methylsterol monooxygenase 1 decreases expression ISO Piroxicam results in decreased expression of MSMO1 mRNA CTD PMID:21858171 NCBI chr16:26,859,441...26,875,880
Ensembl chr16:26,859,397...26,875,973
JBrowse link
G Mt2A metallothionein 2A decreases expression ISO Piroxicam results in decreased expression of MT2A mRNA CTD PMID:21858171 NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
JBrowse link
G Mx2 MX dynamin like GTPase 2 decreases expression ISO Piroxicam results in decreased expression of MX1 mRNA CTD PMID:19192274 NCBI chr11:38,035,306...38,066,185
Ensembl chr11:38,035,450...38,059,950
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC protein] CTD PMID:12189186 NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
JBrowse link
G Mycbp Myc binding protein multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MYCBP mRNA] CTD PMID:21858171 NCBI chr 5:141,560,192...141,567,399
Ensembl chr 5:141,560,192...141,567,399
JBrowse link
G Naa15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit increases expression ISO Piroxicam results in increased expression of NAA15 mRNA CTD PMID:21858171 NCBI chr 2:140,471,437...140,534,259
Ensembl chr 2:140,471,690...140,534,259
JBrowse link
G Nab1 Ngfi-A binding protein 1 decreases expression ISO Piroxicam results in decreased expression of NAB1 mRNA CTD PMID:21858171 NCBI chr 9:53,906,073...53,945,474
Ensembl chr 9:53,906,073...53,945,473
JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 increases expression ISO Piroxicam results in increased expression of NAP1L1 mRNA CTD PMID:21858171 NCBI chr 7:54,213,305...54,237,880
Ensembl chr 7:54,213,319...54,236,625
JBrowse link
G Nasp nuclear autoantigenic sperm protein decreases expression ISO Piroxicam results in decreased expression of NASP mRNA CTD PMID:21858171 NCBI chr 5:135,446,485...135,472,113
Ensembl chr 5:135,446,962...135,472,116
JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NBR1 mRNA] CTD PMID:21858171 NCBI chr10:89,455,202...89,483,791
Ensembl chr10:89,459,650...89,484,080
JBrowse link
G Ncapd3 non-SMC condensin II complex, subunit D3 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPD3 mRNA] CTD PMID:21858171 NCBI chr 8:28,075,629...28,145,024
Ensembl chr 8:28,075,551...28,144,741
JBrowse link
G Ncapg non-SMC condensin I complex, subunit G decreases expression ISO Piroxicam results in decreased expression of NCAPG mRNA CTD PMID:21858171 NCBI chr14:69,898,268...69,927,885
Ensembl chr14:69,899,128...69,927,938
JBrowse link
G Ncaph non-SMC condensin I complex, subunit H multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPH mRNA] CTD PMID:21858171 NCBI chr 3:119,583,798...119,611,148
Ensembl chr 3:119,583,648...119,611,136
JBrowse link
G Nck1 NCK adaptor protein 1 decreases expression ISO Piroxicam results in decreased expression of NCK1 mRNA CTD PMID:21858171 NCBI chr 8:108,787,797...108,847,779
Ensembl chr 8:108,787,798...108,847,779
JBrowse link
G Ndc80 NDC80 kinetochore complex component multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of NDC80 mRNA] CTD PMID:21858171 NCBI chr 9:119,837,857...119,871,435
Ensembl chr 9:119,839,016...119,871,382
JBrowse link
G Ndufa4l2 NDUFA4, mitochondrial complex associated like 2 decreases expression ISO Piroxicam results in decreased expression of NDUFA4L2 mRNA CTD PMID:19192274 NCBI chr 7:70,821,904...70,824,085
Ensembl chr 7:70,821,957...70,824,085
JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 decreases expression ISO Piroxicam results in decreased expression of NDUFA5 mRNA CTD PMID:21858171 NCBI chr 4:51,590,413...51,598,771
Ensembl chr 4:51,590,413...51,598,771
JBrowse link
G Nek9 NIMA-related kinase 9 increases expression ISO Piroxicam results in increased expression of NEK9 mRNA CTD PMID:21858171 NCBI chr 6:109,121,524...109,162,433
Ensembl chr 6:109,124,330...109,162,267
JBrowse link
G Net1 neuroepithelial cell transforming 1 decreases expression ISO Piroxicam results in decreased expression of NET1 mRNA CTD PMID:21858171 NCBI chr17:69,991,786...70,020,977
Ensembl chr17:70,010,794...70,020,982
JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NFATC3 mRNA CTD PMID:21858171 NCBI chr19:38,039,542...38,114,003
Ensembl chr19:38,039,564...38,114,003
JBrowse link
G Nfe2l1 nuclear factor, erythroid 2-like 1 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of NFE2L1 mRNA] CTD PMID:21858171 NCBI chr10:84,686,762...84,699,313
Ensembl chr10:84,682,460...84,698,886
JBrowse link
G Niban1 niban apoptosis regulator 1 decreases expression ISO Piroxicam results in decreased expression of NIBAN1 mRNA CTD PMID:21858171 NCBI chr13:68,949,665...69,101,600
Ensembl chr13:68,949,665...69,101,588
JBrowse link
G Nid2 nidogen 2 increases expression ISO Piroxicam results in increased expression of NID2 mRNA CTD PMID:19192274 NCBI chr15:4,893,999...4,951,893
Ensembl chr15:4,894,213...4,951,917
JBrowse link
G Nisch nischarin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NISCH mRNA CTD PMID:21858171 NCBI chr16:7,254,372...7,290,670
Ensembl chr16:7,254,974...7,290,561
JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421
JBrowse link
G Nle1 notchless homolog 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NLE1 mRNA] CTD PMID:21858171 NCBI chr10:70,250,959...70,261,880
Ensembl chr10:70,250,959...70,259,553
JBrowse link
G Nme7 NME/NM23 family member 7 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NME7 mRNA CTD PMID:21858171 NCBI chr13:82,607,844...82,737,383
Ensembl chr13:82,626,685...82,737,343
JBrowse link
G Nmt2 N-myristoyltransferase 2 decreases expression ISO Piroxicam results in decreased expression of NMT2 mRNA CTD PMID:21858171 NCBI chr17:78,919,235...78,966,013
Ensembl chr17:78,921,793...78,962,476
JBrowse link
G Nol8 nucleolar protein 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NOL8 mRNA CTD PMID:21858171 NCBI chr17:14,565,794...14,589,154
Ensembl chr17:14,565,794...14,589,154
Ensembl chr17:14,565,794...14,589,154
JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of NOLC1 mRNA CTD PMID:21858171 NCBI chr 1:265,829,055...265,839,819
Ensembl chr 1:265,829,108...265,839,818
JBrowse link
G Npdc1 neural proliferation, differentiation and control, 1 decreases expression ISO Piroxicam results in decreased expression of NPDC1 mRNA CTD PMID:21858171 NCBI chr 3:2,624,231...2,630,672
Ensembl chr 3:2,625,015...2,630,670
JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression ISO Piroxicam results in decreased expression of NR4A3 mRNA CTD PMID:19192274 NCBI chr 5:63,781,801...63,822,890
Ensembl chr 5:63,781,801...63,821,637
JBrowse link
G Nrip1 nuclear receptor interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of NRIP1 mRNA CTD PMID:21858171 NCBI chr11:14,658,225...14,742,478
Ensembl chr11:14,658,225...14,741,563
JBrowse link
G Nrp1 neuropilin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858
JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex decreases expression ISO Piroxicam results in decreased expression of NSL1 mRNA CTD PMID:21858171 NCBI chr13:109,669,646...109,697,849
Ensembl chr13:109,669,680...109,696,918
JBrowse link
G Nudt21 nudix hydrolase 21 decreases expression ISO Piroxicam results in decreased expression of NUDT21 mRNA CTD PMID:21858171 NCBI chr19:11,451,366...11,470,637
Ensembl chr19:11,450,760...11,467,644
JBrowse link
G Nup160 nucleoporin 160 decreases expression ISO Piroxicam results in decreased expression of NUP160 mRNA CTD PMID:21858171 NCBI chr 3:79,496,239...79,562,163
Ensembl chr 3:79,498,179...79,551,128
JBrowse link
G Nup50 nucleoporin 50 decreases expression ISO Piroxicam results in decreased expression of NUP50 mRNA CTD PMID:21858171 NCBI chr 7:125,833,557...125,850,830
Ensembl chr 7:125,833,557...125,850,827
JBrowse link
G Nup85 nucleoporin 85 decreases expression ISO Piroxicam results in decreased expression of NUP85 mRNA CTD PMID:21858171 NCBI chr10:104,118,999...104,137,258
Ensembl chr10:104,118,945...104,137,319
JBrowse link
G Nup88 nucleoporin 88 decreases expression ISO Piroxicam results in decreased expression of NUP88 mRNA CTD PMID:21858171 NCBI chr10:57,581,828...57,606,171
Ensembl chr10:57,581,828...57,606,171
JBrowse link
G Nxt2 nuclear transport factor 2-like export factor 2 increases expression ISO Piroxicam results in increased expression of NXT2 mRNA CTD PMID:21858171 NCBI chr  X:113,509,841...113,517,112
Ensembl chr  X:113,510,621...113,517,102
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of OGT mRNA] CTD PMID:21858171 NCBI chr  X:71,540,870...71,585,906
Ensembl chr  X:71,528,988...71,585,908
JBrowse link
G Olfml2b olfactomedin-like 2B increases expression ISO Piroxicam results in increased expression of OLFML2B mRNA CTD PMID:19192274 NCBI chr13:88,995,301...89,032,487
Ensembl chr13:88,995,316...89,032,487
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase decreases expression ISO Piroxicam results in decreased expression of OPA1 mRNA CTD PMID:21858171 NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
JBrowse link
G Optn optineurin decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of OPTN mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of OPTN mRNA]
CTD PMID:21858171 NCBI chr17:77,167,700...77,218,374
Ensembl chr17:77,167,740...77,218,389
JBrowse link
G Orc6 origin recognition complex, subunit 6 decreases expression ISO Piroxicam results in decreased expression of ORC6 mRNA CTD PMID:21858171 NCBI chr19:27,457,541...27,464,804
Ensembl chr19:27,457,474...27,464,805
JBrowse link
G Pa2g4 proliferation-associated 2G4 increases expression ISO Piroxicam results in increased expression of PA2G4 mRNA CTD PMID:21858171 NCBI chr 7:2,979,587...2,987,055
Ensembl chr 7:2,979,588...2,987,055
JBrowse link
G Pacsin2 protein kinase C and casein kinase substrate in neurons 2 increases expression ISO Piroxicam results in increased expression of PACSIN2 mRNA CTD PMID:21858171 NCBI chr 7:124,224,210...124,317,407
Ensembl chr 7:124,223,633...124,317,379
JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of PAFAH1B1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PAFAH1B1 mRNA]
CTD PMID:21858171 NCBI chr10:61,456,144...61,577,412
Ensembl chr10:61,456,145...61,577,412
JBrowse link
G Palld palladin, cytoskeletal associated protein decreases expression ISO Piroxicam results in decreased expression of PALLD mRNA CTD PMID:21858171 NCBI chr16:31,865,712...31,948,168 JBrowse link
G Pank2 pantothenate kinase 2 increases expression ISO Piroxicam results in increased expression of PANK2 mRNA CTD PMID:21858171 NCBI chr 3:123,807,911...123,841,797
Ensembl chr 3:123,807,952...123,841,797
JBrowse link
G Paxip1 PAX interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of PAXIP1 mRNA CTD PMID:21858171 NCBI chr 4:3,956,931...4,008,326
Ensembl chr 4:3,959,640...4,008,326
JBrowse link
G Pbk PDZ binding kinase decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of PBK mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PBK mRNA]
CTD PMID:21858171 NCBI chr15:42,489,253...42,500,377
Ensembl chr15:42,489,377...42,500,395
JBrowse link
G Pbx1 PBX homeobox 1 increases expression ISO Piroxicam results in increased expression of PBX1 mRNA CTD PMID:21858171 NCBI chr13:86,390,741...86,671,460
Ensembl chr13:86,390,741...86,451,002
JBrowse link
G Pcgf2 polycomb group ring finger 2 increases expression ISO Piroxicam results in increased expression of PCGF2 mRNA CTD PMID:21858171 NCBI chr10:85,631,829...85,642,591
Ensembl chr10:85,632,819...85,636,902
JBrowse link
G Pclaf PCNA clamp associated factor decreases expression ISO Piroxicam results in decreased expression of PCLAF mRNA CTD PMID:21858171 NCBI chr 8:71,514,281...71,526,182
Ensembl chr 8:71,514,281...71,526,182
JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Piroxicam results in decreased expression of PCNA mRNA CTD PMID:21858171 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
JBrowse link
G Pdss1 decaprenyl diphosphate synthase subunit 1 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PDSS1 mRNA] CTD PMID:21858171 NCBI chr17:90,033,432...90,072,506
Ensembl chr17:90,033,539...90,071,408
JBrowse link
G Pgls 6-phosphogluconolactonase increases expression ISO Piroxicam results in increased expression of PGLS mRNA CTD PMID:21858171 NCBI chr16:20,020,444...20,025,930
Ensembl chr16:20,020,444...20,025,930
JBrowse link
G Pgrmc2 progesterone receptor membrane component 2 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PGRMC2 mRNA] CTD PMID:21858171 NCBI chr 2:127,986,106...128,002,005
Ensembl chr 2:127,986,109...128,002,005
JBrowse link
G Phb prohibitin decreases expression ISO Piroxicam results in decreased expression of PHB mRNA CTD PMID:21858171 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PHGDH mRNA] CTD PMID:21858171 NCBI chr 2:200,484,245...200,513,564
Ensembl chr 2:200,484,246...200,513,564
JBrowse link
G Phip pleckstrin homology domain interacting protein increases expression ISO Piroxicam results in increased expression of PHIP mRNA CTD PMID:21858171 NCBI chr 8:90,387,339...90,483,964
Ensembl chr 8:90,392,143...90,483,077
JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of PHLDA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]
CTD PMID:21858171 NCBI chr 1:216,701,345...216,704,479
Ensembl chr 1:216,702,319...216,703,534
JBrowse link
G Pigp phosphatidylinositol glycan anchor biosynthesis, class P decreases expression ISO Piroxicam results in decreased expression of PIGP mRNA CTD PMID:21858171 NCBI chr11:34,592,128...34,598,253
Ensembl chr11:34,592,121...34,598,275
JBrowse link
G Pik3r4 phosphoinositide-3-kinase, regulatory subunit 4 decreases expression ISO Piroxicam results in decreased expression of PIK3R4 mRNA CTD PMID:21858171 NCBI chr 8:114,300,248...114,350,686
Ensembl chr 8:114,300,257...114,350,681
JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha decreases expression ISO Piroxicam results in decreased expression of PILRA mRNA CTD PMID:19192274 NCBI chr12:21,412,598...21,418,621
Ensembl chr12:21,412,538...21,420,169
JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA CTD PMID:21858171 NCBI chr 5:156,677,146...156,689,258
Ensembl chr 5:156,677,146...156,689,415
JBrowse link
G Plat plasminogen activator, tissue type decreases expression ISO Piroxicam results in decreased expression of PLAT mRNA CTD PMID:21858171 NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
JBrowse link
G Plaur plasminogen activator, urokinase receptor decreases expression ISO Piroxicam results in decreased expression of PLAUR mRNA CTD PMID:21858171 NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
JBrowse link
G Plk4 polo-like kinase 4 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA] CTD PMID:21858171 NCBI chr 2:127,686,911...127,705,518
Ensembl chr 2:127,686,925...127,705,518
JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression ISO Piroxicam results in decreased expression of PLPP3 mRNA CTD PMID:19192274 NCBI chr 5:124,690,214...124,765,499
Ensembl chr 5:124,690,214...124,765,498
JBrowse link
G Pls1 plastin 1 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLS1 mRNA] CTD PMID:21858171 NCBI chr 8:103,557,361...103,659,625
Ensembl chr 8:103,557,364...103,608,913
JBrowse link
G Plxnb2 plexin B2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA CTD PMID:21858171 NCBI chr 7:130,135,484...130,161,568
Ensembl chr 7:130,135,464...130,151,880
JBrowse link
G Pnn pinin, desmosome associated protein multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PNN mRNA] CTD PMID:21858171 NCBI chr 6:80,159,364...80,167,677
Ensembl chr 6:80,159,364...80,167,677
JBrowse link
G Pold3 DNA polymerase delta 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLD3 mRNA CTD PMID:21858171 NCBI chr 1:165,085,142...165,122,385
Ensembl chr 1:165,083,622...165,123,455
JBrowse link
G Pole2 DNA polymerase epsilon 2, accessory subunit increases expression
multiple interactions
ISO Piroxicam results in increased expression of POLE2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of POLE2 mRNA]
CTD PMID:21858171 NCBI chr 6:91,494,348...91,532,355
Ensembl chr 6:91,494,393...91,518,996
JBrowse link
G Pole3 DNA polymerase epsilon 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLE3 mRNA CTD PMID:21858171 NCBI chr 5:78,380,813...78,384,047
Ensembl chr 5:78,380,816...78,384,047
JBrowse link
G Polr3k RNA polymerase III subunit K decreases expression ISO Piroxicam results in decreased expression of POLR3K mRNA CTD PMID:21858171 NCBI chr 3:177,374,812...177,379,009
Ensembl chr 3:177,374,812...177,379,008
JBrowse link
G Pop7 POP7 homolog, ribonuclease P/MRP subunit decreases expression ISO Piroxicam results in decreased expression of POP7 mRNA CTD PMID:21858171 NCBI chr12:22,259,713...22,260,754
Ensembl chr12:22,259,713...22,260,754
JBrowse link
G Ppm1b protein phosphatase, Mg2+/Mn2+ dependent, 1B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PPM1B mRNA CTD PMID:21858171 NCBI chr 6:8,219,385...8,280,127
Ensembl chr 6:8,218,696...8,280,124
JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PPP1CB mRNA CTD PMID:21858171 NCBI chr 6:23,548,507...23,581,136
Ensembl chr 6:23,549,317...23,581,052
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of PPP1R15A mRNA] CTD PMID:21858171 NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO Piroxicam results in decreased expression of PPP2R1B mRNA CTD PMID:21858171 NCBI chr 8:55,279,278...55,311,768
Ensembl chr 8:55,279,373...55,301,320
JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA CTD PMID:21858171 NCBI chr 2:241,909,332...242,186,861
Ensembl chr 2:241,909,832...242,184,854
JBrowse link
G Ppp4r2 protein phosphatase 4, regulatory subunit 2 increases expression ISO Piroxicam results in increased expression of PPP4R2 mRNA CTD PMID:19192274 NCBI chr 4:133,285,552...133,323,755
Ensembl chr 4:133,285,552...133,323,755
JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO Piroxicam results in decreased expression of PRC1 mRNA CTD PMID:21858171 NCBI chr 1:142,087,181...142,108,746
Ensembl chr 1:142,087,208...142,108,746
JBrowse link
G Prdm4 PR/SET domain 4 decreases expression ISO Piroxicam results in decreased expression of PRDM4 mRNA CTD PMID:21858171 NCBI chr 7:23,959,932...23,986,535
Ensembl chr 7:23,960,378...23,985,525
JBrowse link
G Prkacb protein kinase cAMP-activated catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PRKACB mRNA CTD PMID:21858171 NCBI chr 2:252,602,197...252,691,886
Ensembl chr 2:252,605,307...252,691,886
JBrowse link
G Prpf18 pre-mRNA processing factor 18 decreases expression ISO Piroxicam results in decreased expression of PRPF18 mRNA CTD PMID:21858171 NCBI chr17:77,601,914...77,632,507
Ensembl chr17:77,601,877...77,663,980
JBrowse link
G Prpf4b pre-mRNA processing factor 4B decreases expression ISO Piroxicam results in decreased expression of PRPF4B mRNA CTD PMID:21858171 NCBI chr17:30,680,454...30,714,542
Ensembl chr17:30,683,640...30,714,495
JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 decreases expression ISO Piroxicam results in decreased expression of PRPS1 mRNA CTD PMID:21858171 NCBI chr  X:111,798,233...111,820,270
Ensembl chr  X:111,798,233...111,820,266
JBrowse link
G Psap prosaposin multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PSAP mRNA] CTD PMID:21858171 NCBI chr20:29,831,302...29,856,876
Ensembl chr20:29,831,314...29,856,875
JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO Piroxicam results in decreased expression of PSAT1 mRNA CTD PMID:21858171 NCBI chr 1:233,124,089...233,145,941
Ensembl chr 1:233,124,092...233,145,941
JBrowse link
G Psma2 proteasome 20S subunit alpha 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of PSMA2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PSMA2 mRNA]
CTD PMID:21858171 NCBI chr17:53,091,937...53,102,324
Ensembl chr17:53,091,933...53,102,342
JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 decreases expression ISO Piroxicam results in decreased expression of PSMC2 mRNA CTD PMID:21858171 NCBI chr 4:9,867,132...9,881,383
Ensembl chr 4:9,867,101...9,881,484
JBrowse link
G Psmc3ip PSMC3 interacting protein increases expression ISO Piroxicam results in increased expression of PSMC3IP mRNA CTD PMID:21858171 NCBI chr10:89,002,109...89,006,075
Ensembl chr10:89,002,116...89,005,213
JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of PSMD12 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PSMD12 mRNA]
CTD PMID:21858171 NCBI chr10:95,706,808...95,725,452
Ensembl chr10:95,706,685...95,725,812
JBrowse link
G Ptger4 prostaglandin E receptor 4 decreases expression ISO Piroxicam results in decreased expression of PTGER4 mRNA CTD PMID:21858171 NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Piroxicam results in decreased activity of PTGS1 protein CTD PMID:9258749 NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
decreases expression
decreases activity
ISO
EXP
Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]
Piroxicam results in decreased expression of PTGS2 mRNA
Piroxicam results in decreased activity of PTGS2 protein
[Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA; Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein]
Piroxicam binds to and results in decreased activity of PTGS2 protein; Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
CTD PMID:9258749, PMID:12925531, PMID:15309881, PMID:15878914, PMID:19147701, PMID:19192274, PMID:19931610 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTP4A1 mRNA CTD PMID:21858171 NCBI chr 9:37,223,363...37,254,222
Ensembl chr 9:37,223,729...37,231,291
JBrowse link
G Ptp4a2 protein tyrosine phosphatase 4A2 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PTP4A2 mRNA] CTD PMID:21858171 NCBI chr 5:148,035,501...148,060,752
Ensembl chr 5:148,051,126...148,060,339
JBrowse link
G Ptx3 pentraxin 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTX3 mRNA CTD PMID:21858171 NCBI chr 2:158,097,843...158,103,653
Ensembl chr 2:158,097,843...158,103,653
JBrowse link
G Rab1a RAB1A, member RAS oncogene family decreases expression ISO Piroxicam results in decreased expression of RAB1A mRNA CTD PMID:21858171 NCBI chr14:104,475,082...104,500,176
Ensembl chr14:104,475,082...104,501,020
JBrowse link
G Rab2a RAB2A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB2A mRNA CTD PMID:21858171 NCBI chr 5:21,632,654...21,696,721
Ensembl chr 5:21,632,926...21,695,519
JBrowse link
G Rab7a RAB7A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB7A mRNA CTD PMID:21858171 NCBI chr 4:119,910,461...119,963,065
Ensembl chr 4:119,910,478...119,959,173
JBrowse link
G Rab8a RAB8A, member RAS oncogene family increases expression ISO Piroxicam results in increased expression of RAB8A mRNA CTD PMID:21858171 NCBI chr16:19,355,047...19,376,776
Ensembl chr16:19,355,048...19,376,776
JBrowse link
G Rabep1 rabaptin, RAB GTPase binding effector protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RABEP1 mRNA CTD PMID:21858171 NCBI chr10:57,462,272...57,579,901
Ensembl chr10:57,462,447...57,579,898
JBrowse link
G Racgap1 Rac GTPase-activating protein 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA] CTD PMID:21858171 NCBI chr 7:141,277,303...141,308,849
Ensembl chr 7:141,277,312...141,307,233
JBrowse link
G Rad1 RAD1 checkpoint DNA exonuclease decreases expression ISO Piroxicam results in decreased expression of RAD1 mRNA CTD PMID:21858171 NCBI chr 2:60,461,513...60,469,646
Ensembl chr 2:60,461,551...60,469,685
JBrowse link
G Rad17 RAD17 checkpoint clamp loader component increases expression ISO Piroxicam results in increased expression of RAD17 mRNA CTD PMID:21858171 NCBI chr 2:30,634,353...30,664,618
Ensembl chr 2:30,634,354...30,664,163
JBrowse link
G Rad50 RAD50 double strand break repair protein multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RAD50 mRNA] CTD PMID:21858171 NCBI chr10:39,002,130...39,054,042
Ensembl chr10:39,001,498...39,054,142
JBrowse link
G Rad51ap1 RAD51 associated protein 1 decreases expression ISO Piroxicam results in decreased expression of RAD51AP1 mRNA CTD PMID:21858171 NCBI chr 4:159,469,803...159,482,869
Ensembl chr 4:159,469,804...159,482,869
JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO Piroxicam results in decreased expression of RANBP1 mRNA CTD PMID:21858171 NCBI chr11:86,890,585...86,898,818
Ensembl chr11:86,890,585...86,898,818
JBrowse link
G Ranbp2 RAN binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RANBP2 mRNA CTD PMID:21858171 NCBI chr20:28,027,054...28,076,664
NCBI chr20:28,365,538...28,375,676
Ensembl chr20:28,027,054...28,076,664
Ensembl chr20:28,027,054...28,076,664
JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression ISO Piroxicam results in decreased expression of RB1 mRNA CTD PMID:21858171 NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
JBrowse link
G Rbbp4 RB binding protein 4, chromatin remodeling factor decreases expression ISO Piroxicam results in decreased expression of RBBP4 mRNA CTD PMID:21858171 NCBI chr 5:147,499,880...147,535,240
Ensembl chr 5:147,499,882...147,535,240
JBrowse link
G Rbm25 RNA binding motif protein 25 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RBM25 mRNA] CTD PMID:21858171 NCBI chr 6:107,117,888...107,165,538 JBrowse link
G Rbx1 ring-box 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RBX1 mRNA CTD PMID:21858171 NCBI chr 7:122,700,849...122,710,907
Ensembl chr 7:122,700,854...122,709,935
JBrowse link
G Rdh11 retinol dehydrogenase 11 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RDH11 mRNA] CTD PMID:21858171 NCBI chr 6:102,356,498...102,372,618
Ensembl chr 6:102,356,492...102,372,611
JBrowse link
G Recql RecQ like helicase decreases expression ISO Piroxicam results in decreased expression of RECQL mRNA CTD PMID:21858171 NCBI chr 4:176,581,892...176,606,520
Ensembl chr 4:176,581,897...176,606,382
JBrowse link
G Reep5 receptor accessory protein 5 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of REEP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of REEP5 mRNA]
CTD PMID:21858171 NCBI chr18:27,128,462...27,159,693
Ensembl chr18:27,128,464...27,159,693
JBrowse link
G Rexo4 REX4 homolog, 3'-5' exonuclease multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of REXO4 mRNA CTD PMID:21858171 NCBI chr 3:5,500,578...5,510,908
Ensembl chr 3:5,500,589...5,510,908
JBrowse link
G Rfc2 replication factor C subunit 2 decreases expression ISO Piroxicam results in decreased expression of RFC2 mRNA CTD PMID:21858171 NCBI chr12:25,130,375...25,143,480
Ensembl chr12:25,130,377...25,143,480
JBrowse link
G Rfc3 replication factor C subunit 3 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RFC3 mRNA] CTD PMID:21858171 NCBI chr12:1,460,581...1,471,344
Ensembl chr12:1,460,538...1,471,357
JBrowse link
G Rfc5 replication factor C subunit 5 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA] CTD PMID:21858171 NCBI chr12:44,931,494...44,941,051
Ensembl chr12:44,931,494...44,941,324
JBrowse link
G Rgs4 regulator of G-protein signaling 4 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RGS4 mRNA] CTD PMID:19192274, PMID:21858171 NCBI chr13:88,054,817...88,061,108
Ensembl chr13:88,054,817...88,061,108
JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of RIPK2 mRNA CTD PMID:19192274 NCBI chr 5:29,838,713...29,870,390
Ensembl chr 5:29,838,747...29,870,735
JBrowse link
G Rnaseh1 ribonuclease H1 increases expression ISO Piroxicam results in increased expression of RNASEH1 mRNA CTD PMID:21858171 NCBI chr 6:47,916,188...47,925,582
Ensembl chr 6:47,916,188...47,925,571
JBrowse link
G Rnd3 Rho family GTPase 3 increases expression ISO Piroxicam results in increased expression of RND3 mRNA CTD PMID:21858171 NCBI chr 3:36,643,374...36,660,727
Ensembl chr 3:36,642,587...36,660,758
JBrowse link
G Rnf139 ring finger protein 139 decreases expression ISO Piroxicam results in decreased expression of RNF139 mRNA CTD PMID:21858171 NCBI chr 7:98,770,840...98,782,025
Ensembl chr 7:98,770,840...98,782,025
JBrowse link
G Rnf19b ring finger protein 19B decreases expression ISO Piroxicam results in decreased expression of RNF19B mRNA CTD PMID:19192274 NCBI chr 5:147,246,032...147,270,892
Ensembl chr 5:147,246,037...147,270,957
JBrowse link
G Rpa2 replication protein A2 decreases expression ISO Piroxicam results in decreased expression of RPA2 mRNA CTD PMID:21858171 NCBI chr 5:150,957,041...150,967,597
Ensembl chr 5:150,957,001...150,968,269
JBrowse link
G Rpia ribose 5-phosphate isomerase A decreases expression ISO Piroxicam results in decreased expression of RPIA mRNA CTD PMID:21858171 NCBI chr 4:98,568,028...98,593,664
Ensembl chr 4:98,568,028...98,593,664
JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO Piroxicam results in decreased expression of RRM2 mRNA CTD PMID:21858171 NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 decreases expression ISO Piroxicam results in decreased expression of RSAD2 mRNA CTD PMID:19192274 NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
JBrowse link
G Rsu1 Ras suppressor protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RSU1 mRNA CTD PMID:21858171 NCBI chr17:80,388,477...80,577,338
Ensembl chr17:80,389,157...80,577,027
JBrowse link
G RT1-DMb RT1 class II, locus DMb affects expression ISO Piroxicam affects the expression of HLA-DMB mRNA CTD PMID:25811541 NCBI chr20:3,945,383...3,952,838
Ensembl chr20:5,227,045...5,234,290
JBrowse link
G RT1-S3 RT1 class Ib, locus S3 decreases expression ISO Piroxicam results in decreased expression of HLA-E mRNA CTD PMID:21858171 NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
JBrowse link
G Rtn3 reticulon 3 increases expression ISO Piroxicam results in increased expression of RTN3 mRNA CTD PMID:21858171 NCBI chr 1:222,677,359...222,734,307
Ensembl chr 1:222,677,365...222,734,241
JBrowse link
G Rybp RING1 and YY1 binding protein decreases expression ISO Piroxicam results in decreased expression of RYBP mRNA CTD PMID:21858171 NCBI chr 4:132,689,623...132,740,823
Ensembl chr 4:132,689,531...132,740,938
JBrowse link
G Sap30 Sin3A associated protein 30 decreases expression ISO Piroxicam results in decreased expression of SAP30 mRNA CTD PMID:21858171 NCBI chr16:36,115,942...36,121,310
Ensembl chr16:36,116,258...36,121,097
JBrowse link
G Sar1a secretion associated, Ras related GTPase 1A decreases expression ISO Piroxicam results in decreased expression of SAR1A mRNA CTD PMID:21858171 NCBI chr20:31,298,269...31,310,676
Ensembl chr20:31,265,483...31,310,674
JBrowse link
G Sars1 seryl-tRNA synthetase 1 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of SARS1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS1 mRNA]
CTD PMID:21858171 NCBI chr 2:211,219,743...211,235,475
Ensembl chr 2:211,219,750...211,235,467
JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAT1 mRNA CTD PMID:21858171 NCBI chr  X:43,626,480...43,629,767
Ensembl chr  X:43,625,169...43,629,765
JBrowse link
G Sav1 salvador family WW domain containing protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAV1 mRNA CTD PMID:21858171 NCBI chr 6:92,376,470...92,398,678
Ensembl chr 6:92,376,093...92,398,525
JBrowse link
G Scd stearoyl-CoA desaturase decreases expression ISO Piroxicam results in decreased expression of SCD mRNA CTD PMID:21858171 NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEC31A mRNA CTD PMID:21858171 NCBI chr14:10,854,713...10,909,579
Ensembl chr14:10,854,682...10,909,612
JBrowse link
G Sel1l SEL1L adaptor subunit of ERAD E3 ubiquitin ligase decreases expression ISO Piroxicam results in decreased expression of SEL1L mRNA CTD PMID:21858171 NCBI chr 6:115,572,683...115,616,904
Ensembl chr 6:115,572,649...115,616,859
JBrowse link
G Selenow selenoprotein W decreases expression ISO Piroxicam results in decreased expression of SELENOW mRNA CTD PMID:21858171 NCBI chr 1:77,530,692...77,535,765
Ensembl chr 1:77,533,148...77,535,681
Ensembl chr 1:77,533,148...77,535,681
JBrowse link
G Sell selectin L affects expression ISO Piroxicam affects the expression of SELL protein CTD PMID:12147693 NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
JBrowse link
G Sephs1 selenophosphate synthetase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEPHS1 mRNA CTD PMID:21858171 NCBI chr17:77,312,562...77,340,934
Ensembl chr17:77,312,562...77,340,934
JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SERTAD2 mRNA CTD PMID:21858171 NCBI chr14:104,786,649...104,890,022
Ensembl chr14:104,821,215...104,886,197
JBrowse link
G Sesn1 sestrin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SESN1 mRNA CTD PMID:21858171 NCBI chr20:46,667,116...46,758,306
Ensembl chr20:46,667,121...46,758,305
JBrowse link
G Sf3a3 splicing factor 3a, subunit 3 decreases expression ISO Piroxicam results in decreased expression of SF3A3 mRNA CTD PMID:21858171 NCBI chr 5:142,702,721...142,722,350
Ensembl chr 5:142,702,685...142,722,341
JBrowse link
G Sh2b3 SH2B adaptor protein 3 increases expression ISO Piroxicam results in increased expression of SH2B3 mRNA CTD PMID:21858171 NCBI chr12:40,261,990...40,265,757
Ensembl chr12:40,244,081...40,265,757
JBrowse link
G Sh3glb1 SH3 domain -containing GRB2-like endophilin B1 decreases expression ISO Piroxicam results in decreased expression of SH3GLB1 mRNA CTD PMID:21858171 NCBI chr 2:250,709,812...250,744,216
Ensembl chr 2:250,709,439...250,744,196
JBrowse link
G Shcbp1 SHC binding and spindle associated 1 multiple interactions
increases expression
ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of SHCBP1 mRNA] CTD PMID:21858171 NCBI chr16:90,613,826...90,642,683
Ensembl chr16:90,613,870...90,641,420
JBrowse link
G Sinhcaf SIN3-HDAC complex associated factor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SINHCAF mRNA CTD PMID:21858171 NCBI chr 4:183,401,314...183,426,439
Ensembl chr 4:183,401,318...183,426,439
JBrowse link
G Siva1 SIVA1, apoptosis-inducing factor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SIVA1 mRNA] CTD PMID:21858171 NCBI chr 6:137,209,999...137,214,379
Ensembl chr 6:137,210,052...137,214,388
JBrowse link
G Skp1 S-phase kinase-associated protein 1 decreases expression ISO Piroxicam results in decreased expression of SKP1 mRNA CTD PMID:21858171 NCBI chr10:37,594,578...37,609,498
Ensembl chr10:37,594,578...37,609,498
JBrowse link
G Skp2 S-phase kinase associated protein 2 decreases expression ISO Piroxicam results in decreased expression of SKP2 mRNA CTD PMID:21858171 NCBI chr 2:58,506,146...58,534,211
Ensembl chr 2:58,506,151...58,534,211
JBrowse link
G Slc16a1 solute carrier family 16 member 1 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA] CTD PMID:21858171 NCBI chr 2:207,108,552...207,129,352
Ensembl chr 2:207,108,552...207,128,554
JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO Piroxicam results in decreased activity of SLC22A2 protein CTD PMID:12388633 NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
JBrowse link
G Slc22a25 solute carrier family 22, member 25 decreases activity ISO Piroxicam results in decreased activity of SLC22A9 protein CTD PMID:12388633 NCBI chr 1:224,596,886...224,698,512
Ensembl chr 1:224,596,887...224,698,514
JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases activity
multiple interactions
ISO
EXP
Piroxicam results in decreased activity of SLC22A6 protein
Piroxicam inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]
CTD PMID:10336520, PMID:12388633 NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
JBrowse link
G Slc22a7 solute carrier family 22 member 7 decreases activity ISO Piroxicam results in decreased activity of SLC22A7 protein CTD PMID:12388633 NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766
JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions EXP Piroxicam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] CTD PMID:10224140 NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
JBrowse link
G Slc25a12 solute carrier family 25 member 12 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA] CTD PMID:21858171 NCBI chr 3:57,881,951...57,998,214
Ensembl chr 3:57,882,370...57,957,346
JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC25A13 mRNA] CTD PMID:21858171 NCBI chr 4:31,134,165...31,757,006
Ensembl chr 4:31,608,269...31,730,386
JBrowse link
G Slc3a2 solute carrier family 3 member 2 decreases expression ISO Piroxicam results in decreased expression of SLC3A2 mRNA CTD PMID:21858171 NCBI chr 1:224,906,566...224,921,029
Ensembl chr 1:224,906,554...224,921,092
JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Piroxicam results in increased expression of SLC5A3 mRNA CTD PMID:21858171 NCBI chr11:32,229,366...32,231,812 JBrowse link
G Slc6a15 solute carrier family 6 member 15 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SLC6A15 mRNA] CTD PMID:21858171 NCBI chr 7:45,328,207...45,381,920
Ensembl chr 7:45,328,105...45,382,229
JBrowse link
G Slc6a8 solute carrier family 6 member 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 NCBI chr  X:157,129,987...157,139,321
Ensembl chr  X:157,129,987...157,139,291
JBrowse link
G Slc7a11 solute carrier family 7 member 11 decreases expression ISO Piroxicam results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
JBrowse link
G Slc7a5 solute carrier family 7 member 5 decreases expression ISO Piroxicam results in decreased expression of SLC7A5 mRNA CTD PMID:21858171 NCBI chr19:54,693,959...54,722,563
Ensembl chr19:54,693,959...54,722,563
JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression ISO Piroxicam results in increased expression of SLC7A8 mRNA CTD PMID:19192274 NCBI chr15:33,369,245...33,428,942
Ensembl chr15:33,369,216...33,428,973
JBrowse link
G Slit2 slit guidance ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SLIT2 mRNA CTD PMID:21858171 NCBI chr14:66,831,848...67,171,491
Ensembl chr14:66,831,848...67,170,361
JBrowse link
G Smarca5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 decreases expression ISO Piroxicam results in decreased expression of SMARCA5 mRNA CTD PMID:21858171 NCBI chr19:30,936,703...30,969,454
Ensembl chr19:30,936,703...30,969,454
JBrowse link
G Smarce1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 decreases expression ISO Piroxicam results in decreased expression of SMARCE1 mRNA CTD PMID:21858171 NCBI chr10:87,116,827...87,138,890
Ensembl chr10:87,116,827...87,137,965
JBrowse link
G Smc2 structural maintenance of chromosomes 2 decreases expression ISO Piroxicam results in decreased expression of SMC2 mRNA CTD PMID:21858171 NCBI chr 5:68,717,509...68,764,080
Ensembl chr 5:68,717,519...68,763,850
JBrowse link
G Smc3 structural maintenance of chromosomes 3 decreases expression ISO Piroxicam results in decreased expression of SMC3 mRNA CTD PMID:21858171 NCBI chr 1:274,310,120...274,352,856
Ensembl chr 1:274,309,758...274,352,854
JBrowse link
G Sms spermine synthase decreases expression ISO Piroxicam results in decreased expression of SMS mRNA CTD PMID:19192274 NCBI chr  X:40,363,646...40,415,110
Ensembl chr  X:40,363,646...40,415,109
JBrowse link
G Snrnp40 small nuclear ribonucleoprotein U5 subunit 40 decreases expression ISO Piroxicam results in decreased expression of SNRNP40 mRNA CTD PMID:21858171 NCBI chr 5:148,577,498...148,610,658
Ensembl chr 5:148,577,332...148,610,639
JBrowse link
G Snrpa small nuclear ribonucleoprotein polypeptide A decreases expression ISO Piroxicam results in decreased expression of SNRPA mRNA CTD PMID:21858171 NCBI chr 1:83,999,670...84,008,429
Ensembl chr 1:83,999,671...84,008,293
JBrowse link
G Snrpa1 small nuclear ribonucleoprotein polypeptide A' increases expression ISO Piroxicam results in increased expression of SNRPA1 mRNA CTD PMID:21858171 NCBI chr 1:126,961,389...126,974,453
Ensembl chr 1:126,961,389...126,974,453
JBrowse link
G Snrpd1 small nuclear ribonucleoprotein D1 polypeptide multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SNRPD1 mRNA CTD PMID:21858171 NCBI chr18:1,866,066...1,876,613
Ensembl chr18:1,866,080...1,876,613
JBrowse link
G Snx5 sorting nexin 5 decreases expression ISO Piroxicam results in decreased expression of SNX5 mRNA CTD PMID:21858171 NCBI chr 3:138,378,032...138,397,944
Ensembl chr 3:138,378,202...138,397,870
JBrowse link
G Sod2 superoxide dismutase 2 decreases expression ISO Piroxicam results in decreased expression of SOD2 mRNA CTD PMID:19192274 NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
JBrowse link
G Spag5 sperm associated antigen 5 decreases expression ISO Piroxicam results in decreased expression of SPAG5 mRNA CTD PMID:21858171 NCBI chr10:65,552,780...65,585,773
Ensembl chr10:65,566,171...65,585,760
Ensembl chr10:65,566,171...65,585,760
JBrowse link
G Sparc secreted protein acidic and cysteine rich decreases expression ISO Piroxicam results in decreased expression of SPARC mRNA CTD PMID:21858171 NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
JBrowse link
G Spcs2 signal peptidase complex subunit 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of SPCS2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SPCS2 mRNA]
CTD PMID:21858171 NCBI chr 1:164,829,896...164,849,749
Ensembl chr 1:164,829,896...164,849,749
JBrowse link
G Spdl1 spindle apparatus coiled-coil protein 1 increases expression ISO Piroxicam results in increased expression of SPDL1 mRNA CTD PMID:21858171 NCBI chr10:19,628,070...19,652,914
Ensembl chr10:19,628,258...19,652,898
JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression ISO Piroxicam results in decreased expression of SPP1 mRNA CTD PMID:21858171 NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
JBrowse link
G Sptlc2 serine palmitoyltransferase, long chain base subunit 2 decreases expression ISO Piroxicam results in decreased expression of SPTLC2 mRNA CTD PMID:21858171 NCBI chr 6:111,334,408...111,417,960
Ensembl chr 6:111,339,136...111,417,954
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SQSTM1 mRNA] CTD PMID:21858171 NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
JBrowse link
G Srsf1 serine and arginine rich splicing factor 1 increases expression ISO Piroxicam results in increased expression of SRSF1 mRNA CTD PMID:21858171 NCBI chr10:75,334,200...75,341,197
Ensembl chr10:75,335,146...75,341,197
JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 decreases expression ISO Piroxicam results in decreased expression of SRSF10 mRNA CTD PMID:21858171 NCBI chr 5:154,205,358...154,219,550
Ensembl chr 5:154,205,402...154,213,801
JBrowse link
G Srsf2 serine and arginine rich splicing factor 2 decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of SRSF2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SRSF2 mRNA]
CTD PMID:21858171 NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
JBrowse link
G Srsf3 serine and arginine rich splicing factor 3 multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SRSF3 mRNA] CTD PMID:21858171 NCBI chr20:6,288,285...6,298,218
Ensembl chr20:6,288,267...6,298,213
JBrowse link
G Srsf6 serine and arginine rich splicing factor 6 decreases expression ISO Piroxicam results in decreased expression of SRSF6 mRNA CTD PMID:21858171 NCBI chr 3:159,305,345...159,310,668
Ensembl chr 3:159,305,345...159,310,668
JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression ISO Piroxicam results in decreased expression of SRSF7 mRNA CTD PMID:21858171 NCBI chr 6:2,879,312...2,886,505
Ensembl chr 6:2,880,518...2,886,465
JBrowse link
G Ssr3 signal sequence receptor subunit 3 decreases expression ISO Piroxicam results in decreased expression of SSR3 mRNA CTD PMID:21858171 NCBI chr 2:156,010,997...156,023,853
Ensembl chr 2:156,011,002...156,014,527
JBrowse link
G Ssx2ip SSX family member 2 interacting protein multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SSX2IP mRNA] CTD PMID:21858171 NCBI chr 2:252,263,323...252,296,049
Ensembl chr 2:252,263,386...252,296,051
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STAT3 mRNA CTD PMID:21858171 NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression ISO Piroxicam results in decreased expression of STAT4 mRNA CTD PMID:19192274 NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STC2 mRNA CTD PMID:21858171 NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
JBrowse link
G Stip1 stress-induced phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of STIP1 mRNA CTD PMID:21858171 NCBI chr 1:222,274,133...222,293,139
Ensembl chr 1:222,274,133...222,293,148
JBrowse link
G Stk39 serine threonine kinase 39 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of STK39 mRNA CTD PMID:21858171 NCBI chr 3:54,359,449...54,625,702
Ensembl chr 3:54,359,451...54,625,414
JBrowse link
G Stmn1 stathmin 1 decreases expression ISO Piroxicam results in decreased expression of STMN1 mRNA CTD PMID:21858171 NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
JBrowse link
G Sts steroid sulfatase increases expression ISO Piroxicam results in increased expression of STS mRNA CTD PMID:19192274 NCBI chr  X:45,420,418...45,428,748
Ensembl chr  X:45,420,596...45,428,750
JBrowse link
G Sucla2 succinate-CoA ligase ADP-forming subunit beta decreases expression ISO Piroxicam results in decreased expression of SUCLA2 mRNA CTD PMID:21858171 NCBI chr15:55,461,695...55,516,954
Ensembl chr15:55,461,695...55,516,952
JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases activity ISO Piroxicam results in decreased activity of SULT1A1 protein CTD PMID:17073578 NCBI chr 1:198,100,586...198,104,106
Ensembl chr 1:198,100,586...198,104,109
JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein increases expression ISO Piroxicam results in increased expression of SYNCRIP mRNA CTD PMID:21858171 NCBI chr 8:96,100,692...96,266,342
Ensembl chr 8:96,105,025...96,266,342
JBrowse link
G Tcf3 transcription factor 3 decreases expression ISO Piroxicam results in decreased expression of TCF3 mRNA CTD PMID:21858171 NCBI chr 7:12,146,642...12,168,400
Ensembl chr 7:12,144,162...12,168,410
JBrowse link
G Tdg thymine-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of TDG mRNA CTD PMID:21858171 NCBI chr 7:27,194,000...27,213,676
Ensembl chr 7:27,193,998...27,214,236
JBrowse link
G Terf2 telomeric repeat binding factor 2 multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TERF2 mRNA] CTD PMID:21858171 NCBI chr19:39,271,992...39,301,506
Ensembl chr19:39,272,499...39,300,893
JBrowse link
G Tfam transcription factor A, mitochondrial decreases expression ISO Piroxicam results in decreased expression of TFAM mRNA CTD PMID:21858171 NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
JBrowse link
G Tgfa transforming growth factor alpha multiple interactions EXP Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein] CTD PMID:15309881 NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 decreases expression ISO Piroxicam results in decreased expression of TGIF1 mRNA CTD PMID:21858171 NCBI chr 9:119,181,079...119,190,698
Ensembl chr 9:119,181,083...119,190,698
JBrowse link
G Tgm2 transglutaminase 2 decreases expression ISO Piroxicam results in decreased expression of TGM2 mRNA CTD PMID:21858171 NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
JBrowse link
G Thbs2 thrombospondin 2 increases expression ISO Piroxicam results in increased expression of THBS2 mRNA CTD PMID:19192274 NCBI chr 1:56,653,929...56,683,571
Ensembl chr 1:56,653,938...56,683,731
JBrowse link
G Thoc2 THO complex 2 increases expression ISO Piroxicam results in increased expression of THOC2 mRNA CTD PMID:21858171 NCBI chr  X:128,153,824...128,268,327
Ensembl chr  X:128,161,895...128,268,322
JBrowse link
G Timm10 translocase of inner mitochondrial membrane 10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM10 mRNA CTD PMID:21858171 NCBI chr 3:72,226,563...72,230,087
Ensembl chr 3:72,226,613...72,230,084
JBrowse link
G Timm13 translocase of inner mitochondrial membrane 13 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM13 mRNA CTD PMID:21858171 NCBI chr 7:11,677,340...11,678,443
Ensembl chr 7:11,677,340...11,678,442
JBrowse link
G Timm17a translocase of inner mitochondrial membrane 17A decreases expression ISO Piroxicam results in decreased expression of TIMM17A mRNA CTD PMID:21858171 NCBI chr13:52,124,641...52,136,127
Ensembl chr13:52,124,635...52,136,127
JBrowse link
G Timm23 translocase of inner mitochondrial membrane 23 increases expression ISO Piroxicam results in increased expression of TIMM23 mRNA CTD PMID:21858171 NCBI chr16:8,324,038...8,350,067
Ensembl chr16:8,324,036...8,350,067
JBrowse link
G Tipin timeless interacting protein multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TIPIN mRNA] CTD PMID:21858171 NCBI chr 8:69,753,363...69,768,640
Ensembl chr 8:69,753,373...69,768,305
JBrowse link
G Tjp2 tight junction protein 2 multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TJP2 mRNA] CTD PMID:21858171 NCBI chr 1:241,945,816...242,084,044
Ensembl chr 1:241,945,841...242,083,484
JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO Piroxicam results in decreased expression of TK1 mRNA CTD PMID:21858171 NCBI chr10:106,817,556...106,828,888
Ensembl chr10:106,817,601...106,828,884
JBrowse link
G Tlr2 toll-like receptor 2 decreases expression ISO Piroxicam results in decreased expression of TLR2 mRNA CTD PMID:19192274 NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
JBrowse link
G Tm4sf1 transmembrane 4 L six family member 1 decreases expression ISO Piroxicam results in decreased expression of TM4SF1 mRNA CTD PMID:21858171 NCBI chr 2:147,382,866...147,392,062
Ensembl chr 2:147,382,866...147,392,062
JBrowse link
G Tmed7 transmembrane p24 trafficking protein 7 increases expression ISO Piroxicam results in increased expression of TMED7 mRNA CTD PMID:21858171 NCBI chr18:40,579,182...40,586,260
Ensembl chr18:40,579,182...40,586,260
JBrowse link
G Tmem158 transmembrane protein 158 decreases expression ISO Piroxicam results in decreased expression of TMEM158 mRNA CTD PMID:21858171 NCBI chr 8:132,344,710...132,345,708
Ensembl chr 8:132,344,710...132,345,708
JBrowse link
G Tmem43 transmembrane protein 43 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TMEM43 mRNA CTD PMID:21858171 NCBI chr 4:123,118,468...123,133,610
Ensembl chr 4:123,118,468...123,133,609
JBrowse link
G Tmpo thymopoietin multiple interactions
increases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TMPO mRNA] CTD PMID:21858171 NCBI chr 7:31,847,412...31,872,416
Ensembl chr 7:31,847,410...31,872,423
JBrowse link
G Tmx1 thioredoxin-related transmembrane protein 1 decreases expression ISO Piroxicam results in decreased expression of TMX1 mRNA CTD PMID:21858171 NCBI chr 6:92,864,123...92,875,141
Ensembl chr 6:92,864,123...92,874,204
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
[Piroxicam co-treated with Lipopolysaccharides] results in increased secretion of TNF protein
CTD PMID:10328874, PMID:17328244 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Topbp1 DNA topoisomerase II binding protein 1 decreases expression ISO Piroxicam results in decreased expression of TOPBP1 mRNA CTD PMID:21858171 NCBI chr 8:111,790,655...111,835,224
Ensembl chr 8:111,790,678...111,827,151
JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO Piroxicam promotes the reaction [Cisplatin results in increased expression of TP53 protein] CTD PMID:21858171 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tra2a transformer 2 alpha homolog multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TRA2A mRNA CTD PMID:21858171 NCBI chr 4:78,905,380...78,924,203
Ensembl chr 4:78,905,380...78,924,181
JBrowse link
G Traf3ip2 Traf3 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA CTD PMID:21858171 NCBI chr20:44,679,861...44,722,874
Ensembl chr20:44,680,449...44,722,872
JBrowse link
G Trappc4 trafficking protein particle complex 4 decreases expression ISO Piroxicam results in decreased expression of TRAPPC4 mRNA CTD PMID:21858171 NCBI chr 8:48,723,755...48,727,182
Ensembl chr 8:48,723,191...48,727,154
JBrowse link
G Trhde thyrotropin-releasing hormone degrading enzyme decreases expression
multiple interactions
ISO Piroxicam results in decreased expression of TRHDE mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TRHDE mRNA]
CTD PMID:21858171 NCBI chr 7:57,253,023...57,679,795
Ensembl chr 7:57,253,023...57,679,795
JBrowse link
G Trib3 tribbles pseudokinase 3 decreases expression ISO Piroxicam results in decreased expression of TRIB3 mRNA CTD PMID:21858171 NCBI chr 3:147,814,056...147,819,650
Ensembl chr 3:147,813,473...147,819,571
JBrowse link
G Trim28 tripartite motif-containing 28 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRIM28 mRNA CTD PMID:21858171 NCBI chr 1:65,544,369...65,551,043
Ensembl chr 1:65,544,373...65,551,043
JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TSC22D1 mRNA CTD PMID:21858171 NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
JBrowse link
G Tspan6 tetraspanin 6 decreases expression ISO Piroxicam results in decreased expression of TSPAN6 mRNA CTD PMID:21858171 NCBI chr  X:104,719,930...104,729,606
Ensembl chr  X:104,719,940...104,726,816
JBrowse link
G Ttc3 tetratricopeptide repeat domain 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TTC3 mRNA CTD PMID:21858171 NCBI chr11:34,598,324...34,739,986
Ensembl chr11:34,598,492...34,738,791
JBrowse link
G Ttk Ttk protein kinase multiple interactions
decreases expression
ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] CTD PMID:21858171 NCBI chr 8:91,368,065...91,405,995
Ensembl chr 8:91,368,111...91,405,993
JBrowse link
G Tuba1a tubulin, alpha 1A decreases expression ISO Piroxicam results in decreased expression of TUBA1A mRNA CTD PMID:21858171 NCBI chr 7:140,637,287...140,640,953
Ensembl chr 7:140,637,287...140,640,953
JBrowse link
G Txndc9 thioredoxin domain containing 9 multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNDC9 mRNA] CTD PMID:21858171 NCBI chr 9:44,647,707...44,657,779
Ensembl chr 9:44,647,707...44,657,779
JBrowse link
G Txnip thioredoxin interacting protein multiple interactions
increases expression
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNIP mRNA]
Piroxicam results in increased expression of TXNIP mRNA
CTD PMID:19192274, PMID:21858171 NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
JBrowse link
G Ube2a ubiquitin-conjugating enzyme E2A decreases expression ISO Piroxicam results in decreased expression of UBE2A mRNA CTD PMID:21858171 NCBI chr  X:123,486,988...123,497,726
Ensembl chr  X:123,486,989...123,497,726
JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of UBE2B mRNA] CTD PMID:21858171 NCBI chr10:37,439,947...37,454,867
Ensembl chr10:37,441,284...37,455,022
JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 increases expression ISO Piroxicam results in increased expression of UBE2L3 mRNA CTD PMID:21858171 NCBI chr11:88,047,186...88,088,477
Ensembl chr11:88,047,832...88,088,476
JBrowse link
G Ube2n ubiquitin-conjugating enzyme E2N multiple interactions
decreases expression
ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of UBE2N mRNA] CTD PMID:21858171 NCBI chr 7:36,610,147...36,640,190
Ensembl chr 7:36,610,147...36,640,189
JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 decreases expression ISO Piroxicam results in decreased expression of UBR7 mRNA CTD PMID:21858171 NCBI chr 6:126,636,596...126,656,513
Ensembl chr 6:126,636,491...126,656,507
JBrowse link
G Uchl5 ubiquitin C-terminal hydrolase L5 decreases expression ISO Piroxicam results in decreased expression of UCHL5 mRNA CTD PMID:21858171 NCBI chr13:60,568,102...60,603,812
Ensembl chr13:60,545,635...60,603,811
JBrowse link
G Ung uracil-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of UNG mRNA CTD PMID:21858171 NCBI chr12:48,246,593...48,255,547
Ensembl chr12:48,246,569...48,254,822
JBrowse link
G Usp1 ubiquitin specific peptidase 1 decreases expression ISO Piroxicam results in decreased expression of USP1 mRNA CTD PMID:21858171 NCBI chr 5:117,583,502...117,594,872
Ensembl chr 5:117,583,502...117,594,870
JBrowse link
G Usp16 ubiquitin specific peptidase 16 increases expression ISO Piroxicam results in increased expression of USP16 mRNA CTD PMID:21858171 NCBI chr11:27,101,213...27,130,345
Ensembl chr11:27,101,227...27,130,341
JBrowse link
G Usp46 ubiquitin specific peptidase 46 decreases expression ISO Piroxicam results in decreased expression of USP46 mRNA CTD PMID:21858171 NCBI chr14:36,687,134...36,755,360
Ensembl chr14:36,687,134...36,755,360
JBrowse link
G Utp11 UTP11, small subunit processome component decreases expression ISO Piroxicam results in decreased expression of UTP11 mRNA CTD PMID:21858171 NCBI chr 5:142,666,288...142,681,173
Ensembl chr 5:142,666,289...142,681,173
JBrowse link
G Vcp valosin-containing protein decreases expression ISO Piroxicam results in decreased expression of VCP mRNA CTD PMID:21858171 NCBI chr 5:58,426,548...58,445,953
Ensembl chr 5:58,426,549...58,445,953
JBrowse link
G Vdac3 voltage-dependent anion channel 3 decreases expression ISO Piroxicam results in decreased expression of VDAC3 mRNA CTD PMID:21858171 NCBI chr16:74,292,466...74,308,910
Ensembl chr16:74,292,438...74,308,903
JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Piroxicam results in decreased expression of VEGFA mRNA CTD PMID:21858171 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
JBrowse link
G Vps28 VPS28 subunit of ESCRT-I decreases expression ISO Piroxicam results in decreased expression of VPS28 mRNA CTD PMID:21858171 NCBI chr 7:117,684,339...117,688,187
Ensembl chr 7:117,684,339...117,688,187
JBrowse link
G Vrk1 VRK serine/threonine kinase 1 decreases expression ISO Piroxicam results in decreased expression of VRK1 mRNA CTD PMID:21858171 NCBI chr 6:129,835,788...129,902,839
Ensembl chr 6:129,835,919...129,902,793
JBrowse link
G Vrk2 VRK serine/threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of VRK2 mRNA CTD PMID:21858171 NCBI chr14:110,739,835...110,883,836
Ensembl chr14:110,739,226...110,883,803
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 decreases expression ISO Piroxicam results in decreased expression of WARS1 mRNA CTD PMID:21858171 NCBI chr 6:132,771,026...132,802,262
Ensembl chr 6:132,771,021...132,802,210
JBrowse link
G Xpc XPC complex subunit, DNA damage recognition and repair factor multiple interactions
decreases expression
ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] CTD PMID:21858171 NCBI chr 4:123,134,457...123,161,985
Ensembl chr 4:123,134,457...123,161,985
JBrowse link
G Xpot exportin for tRNA decreases expression ISO Piroxicam results in decreased expression of XPOT mRNA CTD PMID:21858171 NCBI chr 7:63,688,646...63,728,988
Ensembl chr 7:63,690,053...63,728,988
JBrowse link
G Ybx3 Y box binding protein 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of YBX3 mRNA CTD PMID:21858171 NCBI chr 4:165,606,819...165,630,041
Ensembl chr 4:165,606,819...165,630,118
JBrowse link
G Ywhab tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta increases expression ISO Piroxicam results in increased expression of YWHAB mRNA CTD PMID:21858171 NCBI chr 3:160,391,108...160,399,931
Ensembl chr 3:160,391,106...160,399,931
JBrowse link
G Zfp110 zinc finger protein 110 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ZNF274 mRNA CTD PMID:21858171 NCBI chr 1:65,741,769...65,757,709
Ensembl chr 1:65,742,089...65,756,528
JBrowse link
G Zfp207 zinc finger protein 207 decreases expression ISO Piroxicam results in decreased expression of ZNF207 mRNA CTD PMID:21858171 NCBI chr10:67,762,970...67,784,854
Ensembl chr10:67,762,995...67,774,787
JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZFP36L2 mRNA CTD PMID:21858171 NCBI chr 6:7,417,416...7,423,447
Ensembl chr 6:7,417,425...7,421,456
JBrowse link
G Zmat3 zinc finger, matrin type 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZMAT3 mRNA CTD PMID:21858171 NCBI chr 2:118,715,229...118,746,109
Ensembl chr 2:118,721,334...118,745,766
JBrowse link
G Zmpste24 zinc metallopeptidase STE24 decreases expression ISO Piroxicam results in decreased expression of ZMPSTE24 mRNA CTD PMID:21858171 NCBI chr 5:139,982,404...140,015,541
Ensembl chr 5:139,983,680...140,015,541
JBrowse link
G Zmynd8 zinc finger, MYND-type containing 8 decreases expression ISO Piroxicam results in decreased expression of ZMYND8 mRNA CTD PMID:21858171 NCBI chr 3:162,480,766...162,594,145
Ensembl chr 3:162,480,804...162,581,610
JBrowse link
G Zwilch zwilch kinetochore protein increases expression ISO Piroxicam results in increased expression of ZWILCH mRNA CTD PMID:21858171 NCBI chr 8:69,089,449...69,121,420
Ensembl chr 8:69,091,955...69,121,192
JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO Piroxicam results in decreased expression of ZWINT mRNA CTD PMID:21858171 NCBI chr20:17,075,781...17,091,715
Ensembl chr20:17,075,771...17,091,766
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19816
    role 19764
      biological role 19764
        pharmacological role 18825
          analgesic 13078
            piroxicam 584
              ampiroxicam 0
              droxicam 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19816
    subatomic particle 19814
      composite particle 19814
        hadron 19814
          baryon 19814
            nucleon 19814
              atomic nucleus 19814
                atom 19814
                  main group element atom 19702
                    p-block element atom 19702
                      carbon group element atom 19608
                        carbon atom 19597
                          organic molecular entity 19597
                            organic group 18537
                              organic divalent group 18530
                                organodiyl group 18530
                                  carbonyl group 18436
                                    carbonyl compound 18436
                                      carboxylic acid 18114
                                        carboacyl group 17372
                                          univalent carboacyl group 17372
                                            carbamoyl group 17158
                                              carboxamide 17158
                                                monocarboxylic acid amide 14569
                                                  piroxicam 584
                                                    ampiroxicam 0
                                                    droxicam 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.